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CHAPTER I 
 
INTRODUCTION 
 
Ion channels are integral membrane proteins or protein complexes that are critical 
for cell functions that depend on properly maintained electrical and chemical gradients. 
Their direct involvement in a cell’s ability to generate electrical activity implicates ion 
channels in muscle contraction and movement, sensation, and cognition, among other 
complex physiologic functions. Additionally, their contributions to the regulation of 
electrolyte distribution across the cell membrane makes ion channels necessary for 
fundamental processes such as growth and fluid balance. As a result, disruption of normal 
ion channel function can have wide-ranging and substantial consequences, and the so-
called “channelopathies” include epilepsy, cardiac arrhythmias, cystic fibrosis, and many 
others1. 
 
Voltage-gated potassium (KV) channels 
KV channels comprise one family of ion channels. As voltage-gated channels, they 
respond to alterations in membrane potential with conformational changes that allow 
potassium ions to move down their electrochemical gradient into or out of a cell. KV 
channels constitute a diverse class of membrane proteins, and the channels in this subset 
are known to have an essential role in membrane excitability, cellular proliferation, 
synaptic transmission, and epithelial transport.  
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KV channel structure 
The minimal functional unit of a KV channel is a homo- or hetero-tetramer of pore-
forming subunits. There exist more than 75 genes encoding KV channel  subunits 
(categorized into 12 subfamilies, KV1-12), each possessing unique biophysical, 
pharmacological, and assembly properties, and with diverse physiologic functions.  
KCNQ1, also known as KV7.1 or KVLQT1, is an important KV channel  subunit in 
many physiologic systems but is best known for its contributions to cardiac 
electrophysiology, which are discussed below. Briefly, in cardiac myocytes KCNQ1 is a 
component of the channel complex responsible for IKs, a critical repolarizing current in 
the cardiac action potential2,3. KCNQ1 is also implicated in solute transport across the 
membranes of a number of epithelial tissues, including pancreas4,5, kidney6,7, the inner 
ear8,9, and components of the gastrointestinal tract7,9-13. 
Figure 1 illustrates basic structural features of the KCNQ1 monomer and 
homotetramer, which are typical of many KV channels. Limited success at purifying 
KCNQ1 has so far prohibited solving its structure directly. However, our collaborators 
recently published computationally validated models of KCNQ1 monomers and 
homotetramers in the open and closed states, based on KCNQ1 homology to other KV 
channels whose crystal structures were used as templates in computational predictions14.  
These models are useful for developing hypotheses about the mechanics of channel 
opening and closing and its modulation by other proteins.  Notably, each KCNQ1 
monomer has an intracellular N-terminus, four transmembrane segments (S1 through S4) 
that constitute the voltage-sensing domain of the functional tetramer, a pore domain 
2
AB
Figure 1. Structural features of KCNQ1. A, Topology map (left) and open-state model 
(right) of KCNQ1 monomer viewed from membrane plane, with transmembrane
segments designated S1 through S6. Blue denotes regions derived from KV1.2 crystal 
structure template; green denotes regions derived from crystal structure backbone 
coordinates and predicted side chain assignments; orange denotes regions modeled de 
novo using Rosetta. B, Open state model for KCNQ1 homotetramer (each monomer 
assigned a unique color). Left, extracellular view; right, view from membrane plane. 
Modeling data in A and B from Smith et al. Biochemistry, 2007 Dec 11;46(49):14141-52. 
S1
N C
S2 S3 S4 S5 S6
pore loop
3
comprised of the two N-terminal transmembrane segments plus the linker (“pore loop”) 
between them (S5-P-S6), and a long intracellular C-terminus. 
 
Biophysical profile of KV current 
Unlike the other KV7 subtypes (KV7.2 – KV7.5, or KCNQ2 –KCNQ5), which can 
form heterotetramers in various combinations, KCNQ1 only assembles into homo-
tetramers15-19. Whole-cell voltage-clamp recordings allow characterization of the current 
generated by KCNQ1 tetramers in heterologous expression systems, as shown in Figure 
2. Applying a series of step depolarizations from a holding potential of -80 mV to more 
positive membrane potentials in 10 mV increments, we record a set of rapidly activating 
outward currents of increasing amplitude.  Upon returning the membrane to a repolarized 
potential (-30 mV) after each step depolarization, we observe that KCNQ1 channels 
partially inactivate after opening, which is apparent as a “hook” in the tail currents, 
reflecting recovery from the inactivated state before deactivation takes place. 
From the currents recorded under this voltage-clamp protocol, we can calculate 
average peak current density at each depolarizing test potential. Further, we can assess 
the voltage-dependence of activation for KCNQ1 channels, by normalizing peak tail 
current for each test potential to the maximal value for each cell, and plotting normalized 
peak tail current versus voltage. These activation curves can then be fitted with a 
Boltzmann function y = [1 + exp(V-V1/2/k)]-1  to determine the voltage for half-maximal 
activation (V1/2) and a slope factor (k). This set of basic biophysical properties of KCNQ1 
currents is displayed in Figure 2. 
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100 pA
0.5 s
Figure 2. Biophysical properties of KCNQ1 current. A, Representative whole-cell 
currents elicited in CHO cells transiently transfected with KCNQ1 upon applying a 
series of test potentials as illustrated in the voltage-clamp protocol (membrane voltage 
indicated in mV). B, Average peak current-density versus voltage plot (n = 9 cells). C, 
Voltage-dependence of activation. V1/2 =  -7.0 ± 1.9 mV, k = 10.4 ± 0.5 mV.
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Regulation of KV channels 
Research is demonstrating that in vivo, few (if any) KV channels function 
independently of modulatory subunits or other regulatory factors within the cell. Rather, 
they exist as dynamic protein complexes whose constituents include a wide variety of 
proteins and signaling molecules. KCNQ1 channels are no exception; thus, 
characterization of the biophysical properties of KCNQ1 homotetramers under baseline 
conditions provides a critical reference point for assessing their modulation by other 
proteins, signaling molecules, and intracellular conditions. 
Adrenergic stimulation has been identified as one important regulator of KCNQ1-
containing channel complexes20. Adrenergic agonists stimulate cyclic AMP (cAMP) 
activation of protein kinase A (PKA), which phosphorylates a serine in the N terminus of 
KCNQ1, altering its activity21,22. KCNQ1 regulatory activity has also been assigned to 
phosphatidylinositol-4,5-bisphosphate (PIP2), which has been found to stabilize the open 
state and increase current amplitude, as well as slow deactivation23,24. Additionally, cell 
swelling25 and extracellular acidification26 have each been observed to stimulate KCNQ1 
current. 
Recent studies have also implicated the ubiquitous Ca2+-sensing protein calmodulin 
(CaM) as a modulator of KCNQ1 activity27,28. A domain in the C-terminus of KCNQ1 
appears to mediate a biochemical interaction with CaM, and pharmacological disruption 
of the KCNQ1-CaM interaction was found to cause complete suppression of KCNQ1 
current, suggesting that CaM is required for KCNQ1 activity. Further, KCNQ1 voltage-
dependence of activation is shifted toward more negative potentials under conditions of 
high intracellular [Ca2+]. This KCNQ1 Ca2+ sensitivity may be conferred by its 
6
interaction with CaM, as overexpression of a Ca2+-insensitive CaM mutant shifts the 
voltage-dependence of activation of KCNQ1 toward more positive potentials. 
 
KV Channel Accessory Subunits 
The diversity of KV channel composition and activity is also expanded through 
association of pore-forming -subunit tetramers with accessory subunits, of which there 
are three main classes:  KV, KCHIP, and KCNE.  These accessory proteins can have 
profound effects on channel biophysical properties, pharmacological responses, tissue 
distribution, trafficking, and regulation by other cellular factors29. 
 
KCNE proteins 
There are five KCNE genes, each encoding a short protein (103-177 residues in 
length) with a single membrane-spanning domain (Figure 3). The KCNE proteins do not 
generate current when they are expressed alone, but they are characterized by their ability 
to modulate the biophysical properties of potassium channels when coexpressed with KV 
 subunits. In addition to structural similarity, the KCNEs share promiscuity in their 
interactions with KV channel complexes. Lists of KV  subunits that each KCNE protein 
has been shown to modulate to date are illustrated in Figure 4. It is important to note that 
these lists reflect a compilation of findings based on a candidate approach to studying the 
targets of modulation of each KCNE protein, and they will likely be proven incomplete 
as research continues. 
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A
B
Figure 3. Basic structural features of KCNE proteins. A, Topology of a KCNE 
protein with extracellular N-terminus and cytoplasmic C-terminus. B, Amino acid 
sequence alignment of human isoforms of KCNE1-KCNE5. Colors denote predicted 
domains: purple – extracellular, red – transmembrane, blue – intracellular.
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Biophysical modulation of KCNQ1 by KCNE1-KCNE5 
As illustrated in Figure 4, each KCNE subunit is capable of modulating KCNQ1.  
We performed whole-cell voltage-clamp recordings in CHO cells co-expressing each 
KCNQ1-KCNE pair, which allows us to directly compare the modulatory properties of 
the KCNE family members (Figure 5).  As the current traces illustrate, each subunit 
exerts a different modulatory effect on KCNQ1.  Our findings, described below, are 
consistent with other published characterizations of the KCNQ1-KCNE channel 
complexes. 
KCNE1 (also known as minK, “minimal K+ channel protein”) interacts with 
KCNQ1 to increase its current amplitude, slow its activation and deactivation rates, 
remove its inactivation state, and shift its voltage dependence of activation to more 
positive potentials2,30. When KCNE2 (or MiRP1, MinK-related protein 1) is co-expressed 
with KCNQ1, it decreases its current amplitude but renders the channel constitutively 
open31. By contrast, KCNE3 (MiRP2) dramatically increases KCNQ1 current amplitude 
and also confers near-instantaneous activation32,33. KCNE4 (MiRP3) and KCNE5 
(MiRP4) each dramatically inhibit KCNQ1 channel activity at all physiologic voltages, 
though for KCNQ1 plus KCNE5 at supra-physiologic depolarizations an outward current 
with slowed activation properties is restored34,35. Together, these data reflect great 
diversity in the modulatory properties of the various KCNE subunits when they interact 
with KCNQ1. 
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Figure 5.  Whole-cell currents recorded in CHO cells co-transfected with KCNQ1
and KCNE1-5. Each set of traces recorded using voltage-clamp protocol as indicated 
in box. Currents recorded upon +50 mV test depolarization illustrated in red for 
reference.
KCNQ1
KCNQ1 + KCNE1
KCNQ1 + KCNE2
KCNQ1 + KCNE3
KCNQ1 + KCNE4
KCNQ1 + KCNE5
500 ms
500 pA
-80 -80-80
+60
-70
+150
-30
-30
+50
+50
A-E F
A
B
C
D
E
F
11
Mechanisms of KV channel modulation by KCNE proteins 
We have an incomplete understanding of the mechanisms by which KCNE subunits 
exert their modulatory effects on KV channel  subunits such as KCNQ1. One obstacle 
arises from conflicting evidence regarding the number of KCNE proteins that associate 
with a given tetramer of KV channel  subunits. The KCNQ1-KCNE1 channel complex 
has most commonly been the focus of previous investigations into subunit stoichiometry. 
Two studies approached the problem with the use of the K+ channel inhibitor 
charybdotoxin (CTX). Chen et al compared CTX on- and off-rates for cells expressing 
KCNQ1 and KCNE1 monomers (which assemble into their natural channel complexes) 
and cells expressing KCNQ1-KCNE1 concatamers that force defined stoichiometries36. 
Morin and Kobertz performed KCNE1 counting by iterative cell-surface modification37: 
they linked CTX to a cysteine-modifying agent via a cleavable linker, such that upon 
addition of this reagent to cells expressing KCNQ1-KCNE1 channels the compound 
blocks the channel and modifies a cysteine engineered into the extracellular domain of 
KCNE1. Excess reagent is washed out, and CTX is tethered to the channel complex via 
the KCNE1 cysteine, irreversibly blocking the channel until the linker is chemically 
cleaved, leaving one KCNE1 subunit labeled.  This process is repeated until the reagent 
becomes a reversible blocker without cleaving the linker, indicating that all the KCNE1 
subunits have been modified. Both studies provided strong evidence of a fixed 4:2 
KCNQ1-to-KCNE1 subunit ratio. 
However, other studies (whose main limitations include their reliance on isolated 
subdomains of KCNQ1 and KCNE1 or chimeras tethering KCNQ1 to other protein 
domains for structural anchoring, as opposed to native proteins) have suggested that 
12
multiple configurations are possible (from one to four KCNE1 subunits per KCNQ1 
tetramer), depending on the relative expression of each gene38,39. Without a clear 
understanding of subunit stoichiometry it is difficult to work toward a comprehensive 
understanding of the mechanism of KCNE modulation of KCNQ1 or any KV channel 
complex. 
 
KCNE structure-function relationships 
We also lack data clearly defining the relative positioning of KCNE subunits within 
a KV channel complex. No direct crystallographic analysis has been achieved for any 
member of the KCNE family (alone or in complex with a KV channel), but our 
collaborators recently published a 3-dimensional characterization of KCNE1 based on 
NMR spectroscopy of KCNE1 purified into micelles, plus models for KCNE1 docking to 
KCNQ1 in open and closed states based on a number of experimentally derived 
restraints40. Though the authors themselves consider their models “best regarded as being 
medium-resolution in nature, both because of the imperfect precision of structures that 
satisfy the experimental restraints used in docking and because of uncertainty regarding 
some of the assumptions made in the restrained docking calculations”, they provide 
valuable new information about the general locations of KCNE1 subdomains with respect 
to KCNQ1. For example, in the closed state, KCNE1 is found to sit in a cleft between the 
S5-P-S6 pore domain of one KCNQ1 subunit and the voltage sensor of an adjacent 
subunit; in the open state, the N-terminus of the KCNE1 transmembrane domain is in 
contact with three different subunits: S1 from one, S5 and the pore helix from a second, 
and S6 from a third. 
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In many cases, findings from the structural analysis support mechanistic 
postulations derived from previous studies of structure-function correlates for how 
KCNE1 slows KCNQ1 channel activation and enhances conductance.  For example, 
previous studies had identified a specific residue in the KCNE1 transmembrane domain, 
Thr58, to be sufficient for conferring the slow activation properties of KCNE1 to KCNE3 
(in which a valine occupies the equivalent site) and vice versa41-43; in the structural 
models the side chain of Thr58 was found to be well-positioned to interact with KCNQ1. 
Further, the cleft KCNE1 was found to occupy in the open state encompasses the sites of 
four KCNQ1 gain-of-function mutations44-47, supporting a postulation from the structural 
model that KCNE1 may enhance conductance in part by stabilizing the open state of 
KCNQ1 via contact of its transmembrane domain with KCNQ1 residues in this cleft.   
Structural models of the KCNQ1-KCNE1 channel complex may prove to be a 
useful template for understanding some properties universal to all KCNE proteins, but 
given the unique structural and functional features of each KCNE protein, we must 
ultimately study them individually to determine the mechanisms that underlie their 
specific modulatory effects on KV channels. KCNE4 is distinct among the KCNE 
proteins both for its long C-terminus and for its dramatic inhibition of KCNQ1. Our lab 
used KCNE1-KCNE4 and KCNE3-KCNE4 chimeras to study which KCNE4 domains 
are critical for its inhibition of KCNQ1. Notably, the transmembrane residues sufficient 
for swapping activation properties among KCNE1 and KCNE3 were not found to impart 
KCNE1- or KCNE3-like properties to KCNE4 (nor KCNE4-like complete inhibition of 
KCNQ1 to KCNE1 or KCNE3).  
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Instead, the intracellular C-terminus of KCNE4 (residues 59 through 170) conferred 
inhibitory properties to KCNE1 and KCNE3, and also was also found to be necessary for 
KCNE4 inhibition of KCNQ1, as chimeras that replaced the C-terminus of KCNE4 with 
that of KCNE1 or KCNE3 failed to inhibit KCNQ148. Importantly, this study also 
demonstrated that the KCNE4 C-terminus is not sufficient for inhibition of KCNQ1, 
using a chimera that tethered the KCNE4 C-terminus to a surrogate single transmembrane 
domain protein, the lymphocyte CD8 receptor.  The CD8-KCNE4 C-terminus chimera 
did not inhibit KCNQ1 current, despite confirmation that the chimeric protein reached the 
membrane and that it interacts biochemically with KCNQ1. These data and findings from 
several other studies49-51 contribute to an emerging model of cooperativity between the 
transmembrane domain and C-terminus for a KCNE protein to exert its modulatory effect 
on a KV channel. 
Other studies have lent further insight into the particular mechanism of KCNE4 
inhibition of KCNQ1. These include early observations that delayed injection of KCNE4 
mRNA into oocytes previously injected with KCNQ1 does not impair the ability of 
KCNE4 to inhibit KCNQ1 current, suggesting that its inhibitory effect is not dependent 
on early KCNQ1-KCNE4 assembly in the secretory pathway, but could take place in the 
plasma membrane35.  Further, we52 and others35 have demonstrated that expression of 
KCNQ1 at the cell surface is not affected by KCNE4 expression, suggesting that KCNE4 
exerts its inhibitory effect on KCNQ1 via true biophysical modulation of channel gating, 
as opposed to disrupting KCNQ1 trafficking to the membrane or enhancing its 
internalization from the cell surface. These findings each provide additional clues as to 
the mechanism by which KCNE4 exerts its impressive inhibitory effect on KCNQ1. 
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Expression patterns of KCNE1-KCNE5 
All five of the KCNE genes are widely expressed in mammalian tissues. Our lab 
used real-time RT-PCR to quantify relative expression levels of KCNQ1 and KCNE1-5 in 
commercially available panels of cDNA derived from normal human subjects53. Figure 6 
illustrates the findings across 15 tissues. Consistent with previous studies in human and 
other mammalian tissues35,54-56, all of the KCNEs were detected in the heart. KCNE1 is 
also prominently expressed in kidney57,58, testes59, and uterus60,61. KCNE2 expression was 
found to be most significant in colon and small intestine, to complement previous 
findings of its high relative expression in stomach62,63. We found strongest KCNE3 
expression in human kidney, liver, prostate, colon, spleen, ovary, placenta, and 
leukocytes (consistent with previous findings62,64-67), whereas its expression has also been 
previously demonstrated in the trachea67, nasal epithelia64, and portal vein68. Prominent 
expression of KCNE4 was detected in kidney, skeletal muscle, testis, prostate, spleen, 
ovary, and uterus, which overlaps to some extent with a previous report of KCNE4 
expression in mouse35. Finally, we found particularly high KCNE5 expression in brain, 
thymus, ovary, and placenta, whereas previous studies have mostly focused on its 
expression in various regions of the central nervous system55,68. 
Our lab has also characterized KCNE4 expression at the protein level52.  Lysates 
from sixteen human tissues were probed with anti-KCNE4, as shown in the 
representative Western blots in Figure 7. Modest protein expression was detected in 
many of the tissues that demonstrated robust KCNE4 mRNA expression, including brain, 
heart, small intestine, kidney, liver, ovary, pancreas, skeletal muscle, spleen, testis, 
thymus, and uterus. Overall, the mRNA and protein data we have collected provide a 
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Figure 6. Relative expression of KCNQ1 and KCNE genes in human tissues.
Several human tissues were examined by real-time quantitative RT-PCR. Tissues 
were grouped by low (A) and high (B) overall expression for display purposes (note 
differences in the y-axis scale). All data were quantified by gene specific standard 
curves and results were normalized by GAPDH expression. Data are presented as 
mean ± SEM for at least 6 replicates from 2 different pooled (2 or more individuals) 
cDNA samples isolated from healthy individuals. From Lundquist et al. Genomics. 
2006 Jan;87(1):119-28. 
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Figure 7. Expression of KCNE4 protein in human tissues. A, Whole cell lysates
from COS-M6 cells transfected with HA epitope-tagged KCNE4 (+) or non-transfected
cells (−) were subjected to SDS-PAGE and western blotting with the indicated 
immunoreagent. A specific protein with a molecular mass of approximately 28 kDa was 
identified by immunoblotting with either anti-HA or anti-KCNE4. B, Western blot of 
lysates derived from non-transfected cells (NT) or cells expressing each individual 
KCNE protein probed for KCNE4. All lysates were also probed for GAPDH in order to 
demonstrate protein expression. C, Western blot of lysates derived from specified 
human tissues probed for KCNE4. Brain lysates were derived from the cerebellum. 
Colon lysates were derived from the descending colon. Heart lysates were derived from 
the left ventricle. Muscle lysates were derived from skeletal muscle (quadriceps). All 
lysates were also probed for GAPDH. From Manderfield et al. FEBS J. 2008 
Mar;275(6):1336-49. 
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foundational understanding of the distribution of KCNE expression, but further studies 
with increasing specificity (eg. identifying which subregions or specific cell types within 
a tissue express a given KCNE gene) are also needed. 
 
Physiologic functions of KCNE1-KCNE5 
It has become possible to assign physiologic functions to the KCNE proteins, based 
on various combinations of the following findings: disease association with human 
mutation(s) in a KCNE gene, phenotypic findings in Kcne knockout mouse models, 
recapitulation of the biophysical and pharmacological properties of a physiologic current 
upon heterologous expression of the candidate KV-KCNE channel complex, and 
confirmation of native expression of the KCNE gene and its target of modulation by the 
appropriate tissue. In many cases, a single KCNE gene has been implicated in multiple 
physiologic processes, which is not surprising based on the broad expression of KCNE 
genes and their promiscuity in modulating diverse KV channel complexes. Findings to 
date are summarized below. 
 
Cardiac physiology 
KV channels are critical for generation and propagation of action potentials in the 
heart. A generic ventricular cardiac action potential is displayed in Figure 8, along with 
underlying potassium currents. The exact waveform of the action potential varies within 
subregions of the heart, concurrent with variations in the biophysical properties of the 
underlying currents and expression of ion channel subunits. This electrical heterogeneity 
19
Figure 8. Generic human ventricular action potential waveform. X-axis, 
membrane potential; y-axis, time. Underlying currents identified below; red box 
highlights major repolarizing K+ currents. Adapted from Nerbonne JM Trends 
Cardiovasc Med 14, 83-93 (2004).
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across the heart is critical for coordination and fine control of action potential 
propagation, but can also be a substrate for arrhythmia69.  
Ito, IKs, and IKr, the major outward K+ currents expressed by ventricular myocytes, 
are activated at depolarized potentials and contribute to repolarization of the myocyte.  
This directly implicates Ito, IKs, and IKr in determining the length of the action potential 
and the ability of myocytes to adapt to factors such as changing heart rate. Dysregulation 
of these currents can have significant consesquences, as delayed repolarization (which 
translates to a lengthened QT interval on electrocardiogram) may allow for premature 
reactivation of inward calcium and sodium currents, permitting early afterdepolarizations 
and the potential for ventricular fibrillation, arrhythmia, and sudden death. Discovery of 
genetic mutations associated with inherited long QT syndrome (LQTS) has helped 
identify genes that encode the cardiac K+ channel subunits responsible for the various 
repolarizing currents in the human cardiac action potential. 
All five of the KCNE genes are expressed to varying degrees and with distinct 
regional patterns in the heart70 (Figure 9). Over the years, several KCNE proteins have 
been identified as critical modulators of repolarizing K+ currents in the cardiac action 
potential. As mentioned previously, the pore-forming unit of IKs, the ‘slowly activating’ 
repolarizing K+ current, is a KCNQ1 tetramer, originally identified via association of 
KCNQ1 mutations with the most common inherited form of LQTS71. However, 
recapitulation of the pharmacological and biophysical properties of IKs requires co-
expression of KCNQ1 with KCNE12,3, giving rise to the slowly activating and 
deactivating current displayed in Figure 5, first observed in 1996. Shortly thereafter, 
KCNE1 mutations were identified in families with inherited LQTS, which when 
21
Figure 9. Relative expression of KCNQ1 and KCNE genes in human heart. Five 
human cardiac tissues were examined by real-time quantitative RT-PCR: right atrium 
(RA), left atrium (LA), right ventricle (RV), left ventricle (LV), and fetal heart (FH). All 
data were quantified by gene-specific standard curves and values were normalized to 
GAPDH expression. Data are presented as mean ± S.E.M. of at least six replicates 
from two different pooled cDNA samples derived from multiple individuals. From 
Lundquist AL et al. J Mol Cell Cardiol. 2005 Feb;38(2):277-87. 
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characterized in heterologous expression systems were found to reduce IKS current by 
shifting the voltage dependence of activation and accelerating deactivation. Lengthened 
QT interval in the mutation carriers can thus be accounted for by delayed repolarization 
due to reduced IKs. KCNE1 mutations are now recognized to account for approximately 3 
% of inherited LQTS cases72, and cardiac IKs is universally accepted to be generated by a 
channel complex comprised of KCNQ1 and KCNE1 subunits.  
A recent study from our lab assessed whether the other KCNE proteins can 
modulate IKs70.  A stable IKs-expressing cell line was generated by genomic integration of 
a bicistronic KCNE1-IRES2-KCNQ1 cassette, allowing uniform expression of KCNQ1 
and KCNE1 from a single genomic locus, and generating a consistent level of IKs current 
in all cells.  These IKs-expressing cells were then transfected with cDNA encoding each 
of the KCNE subunits, and potassium currents were recorded upon applying a standard 
voltage-clamp protocol (Figure 10). Cells expressing IKs plus EGFP, KCNE1, or KCNE2 
exhibited slowly-activating current with gating properties indistinguishable from the 
transient co-expression of KCNQ1 and KCNE1 in CHO cells. By contrast, expression of 
KCNE3 accelerated activation of IKs while co-expression of either KCNE4 or KCNE5 
suppressed the current. These observations indicate that KCNE3, KCNE4 and KCNE5 
are capable of modulating KCNQ1-KCNE1 channel complexes in vitro and may 
contribute to fine-tuning of IKs in vivo. 
IKr, the ‘rapidly activating’ repolarizing K+ current, was first associated with the KV 
 subunit hERG (‘human ether-a-go-go related gene’, also known as KCNH2 or KV11.1) 
in 199573,74, and dominant-negative hERG mutations were identified in LQTS soon 
after75. However, heterologous expression of hERG alone has revealed differences in the 
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biophysical and pharmacological profiles of its K+ current from those of native IKr73,74,76-
81, suggesting that cardiac IKr channels may be comprised of hERG plus accessory 
subunits. KCNE1 and KCNE2 have each been proposed as modulators of hERG in 
human heart.  
In heterologous expression systems, KCNE1 can be co-immunoprecipitated with 
hERG and was found to increase hERG current density (with little effect on gating 
kinetics or single channel conductance)82, and native ERG and KCNE1 have been co-
immunoprecipitated from horse heart83. Co-expression of KCNE2 and hERG yields 
currents that resemble those of IKr, with more rapid deactivation and less sensitivity to 
external K+ than hERG alone. Further, in vitro translated hERG has been found to 
preferentially assemble with KCNE2 over KCNE184, and native KCNE2 and ERG have 
been co-immunoprecipitated from dog heart85. Loss-of-function mutations in both 
KCNE1 and KCNE2 have been associated with LQTS84,86-90, providing additional 
evidence that either of these subunits could be important for modulating IKr in cardiac 
physiology.  
Ito, the ‘transient outward’ K+ current, accounts for early repolarization in the 
human cardiac action potential. Ito,fast, the predominant component of Ito in most regions 
of mammalian myocardium, is thought to be composed of some combination of KV4.2 or 
KV4.3  subunits plus the KChIP2 accessory subunit, depending on the species91-94. 
Findings of altered Ito current in the Kcne2 knockout mouse plus co-immunoprecipitation 
of KCNE2 and KV4.2 from mouse heart95 implicate KCNE2 as a potential Ito modulator. 
KCNE3 has been demonstrated to be capable of modulating KV4.2 in heterologous 
expression studies, and association of a missense KCNE3 mutation with LQTS provides 
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further evidence that KCNE3 could modulate Ito in vivo96. Finally, KV4.2-KChIP2 
channels97 and KV4.3-KChIP2 channels98 have both been demonstrated to be modulated 
in vitro by KCNE4, suggesting it too could function as a native modulator of Ito. Further, 
KCNE4 was found to co-localize with KV4.2 to transverse tubules of rat cardiac 
myocytes and it was co-immunoprecipitated with KV4.2 and KChIP2 following 
heterologous expression in tsA201 cells97. 
These findings reflect our preliminary understanding of possible roles for the 
KCNE subunits in cardiac physiology, but in many cases further investigation is needed. 
Particularly compelling evidence could emerge from demonstration of native co-
assembly of the candidate channel subunits in cardiac myocytes, characterization of 
additional disease-associated mutants, or findings from knock-down studies in animal 
models whose cardiac electrophysiology closely recapitulates that of humans. 
 
Central nervous system (CNS) physiology 
Like the heart, the main function of the central nervous system requires generation 
and propagation of electrical signals, and thus depends on a wide range of ion channel 
subunits to elicit currents with varying biophysical properties. Expression of all five 
KCNE genes has been demonstrated in human brain53, promoting the possibility that any 
of them could play important roles in modulating neuronal excitability. The M-current, a 
muscarinic-sensitive voltage-and time-dependent K+ current expressed in many regions 
of the brain99, has been the focus of most investigations into possible CNS targets of 
KCNE modulation. Heteromultimers of KCNQ2 and KCNQ3 subunits are thought to 
contribute to M-current channels16,19, and mutations in each have been associated with 
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familial epilepsy100-102. It has been observed that the expression pattern of KCNE2 in the 
brain overlaps significantly with that of KCNQ2 and KCNQ3, that coexpression of 
KCNE2 with KCNQ2-KCNQ3 heteromultimers in COS cells recapitulates many 
biophysical properties of the native M-current, and that the three subunits can be co-
immunoprecipitated following co-expression in COS cells103.  
Studies have also provided evidence for possible contributions of KCNE1 and 
KCNE3 to central nervous system electrophysiology, via possible interactions with KV2.1 
and KV3.1 which may each constitute important neuronal KV channels. Kcne3 was co-
immunoprecipitated with KV2.1 and KV3.1 from rat brain, and KCNE3 has been 
demonstrated to modulate both of these a subunits in CHO cells66. A subsequent study 
also demonstrated modulation of KV3.1 and KV3.2 channels by KCNE1, KCNE2, and 
KCNE3 in CHO cells, further expanding the range of biophysical profiles of K+ currents 
that can be generated by these neuronal channels104. 
Additionally, KCNE4 has been proposed as a modulator of CNS KV channels 
composed of KV1.1 and KV1.3 subunits, based on observations that KCNE4 dramatically 
inhibits these channels in both oocytes and HEK cells105. Like its modulation of KCNQ1, 
KCNE4 is thought to inhibit the KV1 channels via biophysical modulation of channel 
gating at the plasma membrane (as opposed to impairing trafficking of the channel 
subunits), as delayed injection of KCNE4 cDNA was effective at inhibiting channels at 
the membrane, and cell-surface expression of the  subunits was not found to be 
impaired by co-expression of KCNE4. The native functions of KV1 channels in the brain 
are not known, and it is important to note that KV1.1 and KV1.3 are also expressed in 
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peripheral tissues (in many cases with patterns overlapping those of KCNE4) including 
lung, kidney, colon, and uterus. 
Together, these findings provide early leads into potential roles for KCNE subunits 
in the electrophysiology of the central nervous system, but thus far no mutation in any 
KCNE gene has been associated with CNS deficits in humans or experimental models, 
limiting our ability to draw any firm conclusions. 
 
Skeletal muscle physiology 
Another excitable tissue that relies on diverse ion channel activity is skeletal 
muscle. An important study published in 2001 directly implicated KCNE3 in 
maintenance of resting membrane potential in skeletal muscle, via its interaction with 
KV3.4 subunits65. In this study, KCNE3 protein was detected by Western blot in native 
rat sartorius muscle and in the C2C12 skeletal muscle cell line, and was found to co-
localize with KV3.4 in C2C12 cells by immunofluorescence. Further, KCNE3 was 
detected following co-immunoprecipitation with KV3.4 from COS cells co-transfected 
with the two subunits. Evidence of KV3.4 modulation by KCNE3 also emerged from 
voltage-clamp studies performed in CHO cells co-transfected with KV3.4 and KCNE3, 
and the biophysical properties of the KV3.4-KCNE3 channel complex matched those of 
native currents recorded in C2C12 cells. Finally, screening of patients with inherited 
muscle disorders without mutations in known disease-associated genes identified a 
KCNE3 mutation in two unrelated individuals with periodic paralysis. When 
characterized by co-expression with KV3.4 in CHO cells, this KCNE3 mutation was 
found to reduce K+ current and alter resting membrane potential, supporting a causative 
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role for the mutation in pathogenesis and for KCNE3 in normal skeletal muscle 
physiology. 
 
Smooth muscle physiology 
Limited data have been generated to suggest specific physiologic functions 
performed by KCNE subunits in smooth muscle cells, but their expression has been 
confirmed in a number of cell types. For example, expression of Kcne2 and Kcne3 has 
been detected in mouse portal vein myocytes68. ERG channels are thought to contribute 
to K+ conductance and electrical activity of these cells, but native currents differ from 
those recorded upon heterologous expression of ERG subunits alone. Observations that 
Erg1 and Kcne3 transcripts co-localize at the cell membrane68 support postulations that 
KCNE3 may modulate ERG currents in vivo as part of the electrophysiologic profile of 
these vascular smooth muscle cells. 
Expression of KCNE1, KCNE3, and KCNE4 has been demonstrated in mouse106 and 
human myometrium53. Studies in mouse have shown upregulation of Kcne1 (along with 
Kcnq1 and Kcnq5) at the metestrous phase of the estrous cycle106. Further, Kcne1 levels 
have been observed to increase dramatically during late pregnancy in rodents60, though 
the physiologic significance of these findings is not known. 
 
Epithelial physiology 
Although they have been primarily studied for their contributions to the physiology 
of excitable tissues, KV channels expressed in the membranes of epithelial cells have also 
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proven to participate in transepithelial K+ secretion and recycling as a driving force 
behind other channels and transporters. 
One important example of a significant role for KV channels and KCNE subunits in 
epithelial physiology is the observation that KCNQ1 and KCNE2 are necessary for gastric 
acid secretion by parietal cells, which is coupled to K+ intake via the H+/K+-ATPase.  
KCNQ1 was originally identified as the channel responsible for K+ recycling that 
supports the H+/K+ exchanger in a 2001 study107.  KCNQ1 expression in parietal cells 
was localized to the tubulovesicles and apical membrane by immunofluorescence.  
Further, inhibition of KCNQ1 current in parietal cells by chromanol 293B was found to 
completely block acid secretion.  KCNE2 was also observed to be abundantly expressed 
in the stomach, and the K+ current measured in COS cells coexpressing KCNQ1 and 
KCNE2 showed electrophysiologic and pharmacologic similarities to the K+ current 
observed in parietal cells.  A subsequent study108 confirmed that KCNE2 is necessary for 
gastric acid secretion, reporting that a Kcne2-/- mouse model displays a gastric phenotype 
characterized by achlorhydria and hypergastrinemia.   
Similar roles for KCNQ1 and KCNE subunits have been established in the colon 
and small intestine. In colonic crypt cells, a basolateral K+ efflux is responsible for 
recycling K+ in conjunction with Na-K-2Cl cotransport into the cell at the basolateral 
membrane, and for hyperpolarizing the membrane; both phenomena contribute to the 
driving force for luminal Cl- secretion through CFTR at apical membrane. In situ 
hybridization and immunohistochemical studies confirmed the expression of KCNQ1 and 
KCNE3 in colonic crypt cells, and electrophysiologic studies demonstrated numerous 
similarities between K+ currents of colonic crypt cells with those of transfected 
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KCNQ1/KCNE3 channels109.  These findings suggest that a KCNQ1/KCNE3 channel 
may account for the basolateral K+ current that is important for cAMP-stimulated Cl- 
secretion, and thus may also play a role in the pathophysiology of cystic fibrosis and 
secretory diarrhea. 
Preliminary studies have implicated KCNQ1-KCNE1 channel complexes in the 
physiology of the exocrine pancreas. Both subunits are abundantly expressed in 
pancreatic acinar cells58, and a slowly activating K+ current with biophysical properties 
resembling IKs has been recorded in rat pancreatic cells5. Further, pancreatic acinar cells 
from the Kcne1 knockout mouse displayed significant reduction of a chromanol 293B-
sensitive, cholinergic-stimulated, slowly activating K+ current61, suggesting that an IKs-
like current generated by KCNQ1-KCNE1 channel complexes may contribute to the 
electrochemical driving forces that underlie pancreatic secretion of electrolytes and 
enzymes. 
KCNE2 has been directly implicated in thyroid hormone biosynthesis. A 2009 
study110 demonstrated KCNQ1 and KCNE2 form a TSH-stimulated K+ channel in 
thyrocytes responsible for a constitutively active K+ current at the basolateral membrane. 
Kcne2 knockout mice demonstrated a dramatic defect in I- accumulation in thyrocytes, 
which is a critical step in thyroid hormone biosynthesis. As a consequence, pups from 
homozygous Kcne2-/- crosses exhibited cardiomegaly, dwarfism, and alopecia, concurrent 
with decreased serum thyroid hormone and increased thyroid stimulating hormone. 
In many segments of the nephron, K+ flux is critical for maintaining appropriate 
electrochemical gradients that drive the tightly regulated distribution of fluid and 
electrolytes across the membrane. Colocalization of Kcnq1 and Kcne1 has been observed 
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in the luminal membrane of proximal tubules of mouse kidney, and the Kcne1 knockout 
mouse displayed abnormal K+ flux in proximal and distal tubules plus enhanced urinary 
excretion of fluid, Na+, Cl-, and glucose compared to wild-type mice111. KCNE4 has been 
localized to the apical membrane of intercalated cells of the nephron, which are only 
known to express one K+ channel, the voltage- and calcium-dependent BK channel112. 
Subsequent analysis by heterologous expression of BK plus KCNE4 in CHO cells 
revealed that KCNE4 shifts the voltage-dependence of activation of BK channels toward 
more positive potentials, and reduces macroscopic current but not single-channel 
conductance (suggesting that KCNE4 may accelerate turnover of BK channels, which 
was corroborated by biotinylation and pulse-chase experiments).  
Finally, vestibular dark cells of the inner ear are known to rely on functional 
KCNQ1-KCNE1 channel complexes for normal endolymph production.  The expression 
of KCNQ1 and KCNE1 has been observed at the apical surface of vestibular dark 
cells113, and Kcne1 knockout mice are profoundly deaf and demonstrate signs of 
dysfunction of the vestibular organ61. These phenotypes are likely attributable to impaired 
endolymph production, death of sensory hair cells, and degeneration of spiral ganglion 
neurons, which have all been observed in Kcne1 knockout mice, concurrent with 
mislocalization of Kcnq1 in dark cells114. The inner ear phenotype displayed by these 
mice is similar to that in patients with Jervell-Lange-Nielsen syndrome caused by 
mutations in human KCNQ1 or KCNE1. 
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Objective 
As summarized above, the KCNE proteins have already been implicated in a wide 
range of physiologic processes, but our understanding of their exact function is 
incomplete, particularly in the case of KCNE4. Though the modulatory effect KCNE4 
has been observed to exert on some KV channel complexes in vitro - total extinction of 
the current - is perhaps the most striking among the KCNE subunits, we have yet to 
determine how that effect is achieved or for what purpose(s) in physiology. 
In vitro observations of the functional properties of KCNE4 and studies of its 
expression in human heart provide strong, specific leads in cardiac physiology:  KCNE4 
may be an important regulator of IKs and/or Ito and contribute to fine-tuning of the cardiac 
action potential, with implications for heart rhythm and contractility.  Additionally, it is 
important to consider that KCNE4 may have an important function in skeletal muscle or 
in the CNS, tissues that robustly express KCNE4 and that require coordinated activity of 
ion channels for normal function.  Finally, based on the extensive expression of KCNE4 
in epithelial tissues and the emerging recognition of roles for members of the KCNE 
family in epithelial physiology, it is conceivable that KCNE4 may participate in KV 
channel activity in epithelial cells and contribute critically to their proper biological 
function. 
In heterologous expression systems, the most commonly observed modulatory 
effect of KCNE4 on KV channels of varying compositions is dramatic inhibition of 
current. In any physiologic setting, this could implicate KCNE4 as a negative regulator of 
endogenous K+ currents and the cellular functions they contribute to. Grunnet et al.105 
have postulated that, based on the time course of K+ current inhibition by KCNE4 (ie. 
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within hours of its expression), it may provide subacute regulation of cellular functions. 
They also note that this time frame is consistent with typical responses to hormonal 
regulation. Given that KCNE1 has previously been demonstrated to be subject to 
hormonal regulation, this is an intriguing possibility to consider for KCNE4. Speculation 
along these lines draws warranted attention to the fact that we have an extremely limited 
understanding of how KCNE4 is regulated, and new data shedding light on any 
regulatory factors would also be valuable toward understanding its physiologic functions. 
 
Based on the broad expression of KCNE4 by human tissues we hypothesized that 
KCNE4 performs physiologically significant functions in vivo. In this project, we aimed 
to first consider the specific leads in cardiac physiology.  Questions that address some 
crucial limitations of our understanding of function of KCNE4 include: What are the 
protein interacting partners of KCNE4 in native cells?  What are the consequences of the 
absence of KCNE4 on heart rhythm and contractility, and cardiomyocyte 
electrophysiology?  This thesis describes a set of multidisciplinary experiments that make 
use of a Kcne4 knockout mouse and are designed to answer these questions and advance 
our understanding of the physiologic function of KCNE4. 
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CHAPTER II 
 
DISCOVERY OF NOVEL KCNE4 PROTEIN INTERACTING PARTNERS 
 
 The physiologic function of KCNE4 may require interactions with other cellular 
proteins.  From studies in heterologous expression systems, we know that the KCNE 
subunits do not generate current when expressed alone; they are instead characterized by 
their ability to modulate currents generated by KV channel  subunits. We can study 
individual  subunits to see which are susceptible to functional modulation by KCNE4, 
but this candidate approach is inefficient for generating a comprehensive list of channels 
KCNE4 can modulate. In addition to potential targets of its modulation, we might expect 
KCNE4 to have numerous other protein interacting partners, falling into a variety 
different categories. Among the possibilities are up- or down-stream signaling proteins, 
chaperone proteins required for appropriate trafficking, or scaffolding proteins that 
enable KCNE4 to adopt a specific position relative to other components of a given KV 
channel complex.   
 Discovery of any of these potential interacting partners is an important early step 
toward determining the native physiologic function of KCNE4. Establishing a 
complement of KCNE4 interacting partners whose physiologic functions are already 
known could provide useful context when considering potential roles for KCNE4. 
Further, studies of KCNE4 activity in heterologous expression systems will be most 
effective when we can ensure that other proteins relevant to its native function are 
present. 
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 Studying biochemical interactions among membrane proteins has historically been 
difficult because of their hydrophobic nature. KV channel  subunits and accessory 
subunits are no exception. No reliable evidence exists even for the biochemical 
interaction of KCNQ1 and KCNE1 in native tissue, while it is universally accepted 
(based on robust biophysical findings) that they form the K+ channel complex responsible 
for IKs. Years of attempts by our lab and others that have failed to reliably demonstrate an 
interaction between the KCNE proteins and KV alpha subunits in native cells using 
traditional biochemical assays (such as co-immunoprecipitation) provided additional 
motivation for employing an alternative approach: a recently developed screening tool to 
discover novel KCNE4 protein interacting partners. 
  
Methods 
 The split-ubiquitin membrane-based yeast two-hybrid (MbYTH) system is a 
screening tool for identifying biochemical interactions among membrane proteins115,116. 
MbYTH is a modified version of the traditional yeast two-hybrid screen that does not 
require translocation of the bait and prey to the nucleus, and instead takes advantage of 
the ubiquitin-based split protein sensor (USPS) originally developed by Johnsson and 
Varshavsky117,118.  In MbYTH, the bait and prey are fused to complementary halves of 
ubiquitin: Cub (“C-terminal ubiquitin”) and NubG (“N-terminal ubiquitin G”; G denotes 
a single amino acid substitution, I13G, that decreases the affinity of Nub for Cub, to 
prevent spontaneous association). Upon interaction of bait and prey, NubG and Cub come 
together and the reconstituted “split-ubiquitin” is recognized by ubiquitin-specific 
proteases, resulting in cleavage of an artificial transcription factor (LexA-VP16) also 
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built into the bait-Cub fusion construct. The transcription factor then enters the nucleus, 
activating reporter genes that signal an interaction between bait and prey (Figure 11).  
 The specific reporter genes used in this screen include two auxotrophic growth 
markers (HIS3 and ADE2) and lacZ, which encodes the enzyme -galactosidase. The 
yeast reporter strain carries these genes under the control of LexA operators, such that 
they are expressed only when the artificial transcription factor LexA-VP16 is cleaved 
from split ubiquitin, allowing it to translocate to the nucleus. Upon binding of the 
transcription factor to LexA DNA binding domains upstream of these genes, the VP16 
transactivator domain recruits RNA polymerase and initiates their transcription. Thus, the 
interaction between bait and prey is transduced into transcriptional events that can be 
assayed by growth of yeast on media lacking histidine or adenine, or by color 
development in a -galactosidase assay.   
 Further, when ADE2 is not transcribed and the yeast adenine synthesis pathway is 
blocked, a red-colored metabolic intermediate accumulates. Thus, in the absence of a 
protein-protein interaction, yeast colonies are pinkish in color.  By contrast, the presence 
of two interacting proteins activates the ADE2 gene, leading to completion of the adenine 
synthesis pathway and yeast colonies appear faint pink to white, depending on the 
strength of the interaction. 
 MbYTH has been successfully implemented in numerous studies by independent 
groups for small-scale and library-screening applications119-125. Two publications by the 
group that pioneered development of the protocol are dedicated to describing detailed 
methodology115,116. The series of steps we completed are described briefly here: 
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Generation of KCNE4-Cub bait construct 
KCNE4 cDNA was subcloned into the pBT3-STE bait vector (acquired from 
Dualsystems Biotech, Schlieren, Switzerland) for type I integral membrane proteins such 
that KCNE4 is expressed under the weak CYC1 promoter and at the 3’ end is in-frame 
with the Cub-LexA-VP16 cassette. The bait vector also includes the yeast STE2 leader 
sequence for improved targeting of the heterologous bait protein to the yeast membrane. 
Following transformation in E. coli, positive clones were selected via KanR expression 
and bait insertion was confirmed by PCR and sequencing.  The bait vector also includes 
the auxotrophic marker LEU2, allowing for selection in yeast by growth on leucine- 
dropout (leu-) media. 
 
Biochemical validation of bait fusion protein expression in yeast 
The S. cerevisiae reporter strain NMY51 was transformed with the bait construct or 
one of two control constructs: pCCW-Alg5 (positive control bait vector, expresses yeast 
ER protein Alg5 as fusion protein with Cub-LexA-VP16 cassette under the CYC1 
promoter), and pPR3-N (negative control empty prey vector, expresses NubG under 
CYC1 promoter).  Yeast expressing the KCNE4 or control bait constructs were selected 
on leu- dropout media, whereas yeast expressing pPR3-N were selected on tryptophan- 
(trp-) dropout media. Protein lysates were prepared from each strain and used for SDS-
PAGE.  Western blots were performed using polyclonal rabbit anti-KCNE4 or 
monoclonal mouse anti-LexA to probe for the bait fusion proteins (predicted molecular 
weights: KCNE4-Cub-LexA-VP16, approximately 60 kDa; Alg5-Cub-LexA-VP16, 
approximately 77.5 kDa). 
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Functional validation of KCNE4-Cub bait construct by control co-transformations 
Expression and functionality of the bait protein were assessed in yeast using the 
“NubG/NubI” test.  In this test, NMY51 yeast were cotransformed with the KCNE4 or 
Alg5 control bait plus control prey plasmids that express control prey proteins Alg5-
NubG or Alg5-NubI.  (NubI is the wild-type N-terminal portion of ubiquitin that has 
strong affinity for Cub).  Coexpression of Alg5-NubI with a bait-Cub-LexA-VP16 fusion 
protein will result in reconstitution of split ubiquitin and activation of the transcription 
factors if the bait-Cub-LexA-VP16 protein is properly expressed in the ER or plasma 
membrane.  Coexpression of Alg5-NubG with the bait-Cub-LexA-VP16 fusion protein is 
not expected to result in reconstitution of split ubiquitin (unless the bait protein interacts 
with Alg5). 
 
 After verifying proper expression and functionality of our KCNE4-Cub-LexA-
VP16 bait, we sent the bait construct to Dualsystems Biotech, where the remaining steps 
of the library screen were completed: 
 
Bait self-activation test 
Dualsystems assessed whether our bait displayed self-activation of the reporter 
complex.  Yeast reporter strain NMY32 was transformed with the bait, grown in parallel 
on trp-leu- dropout media and trp-leu-histidine-adenine (trp-leu-his-ade-) dropout media, 
and assessed for adeneine and histidine prototrophy and -galactosidase activity. 
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Bait functional analysis 
Dualsystems performed a functional analysis of our bait using the control prey 
clones described in Table 1. Yeast reporter strain NMY32 was co-transformed with our 
bait plus each of these prey clones and growth on trp-leu-, trp-leu-his-, and trp-leu-ade- 
dropout media was assessed to determine if our bait was functional in the interaction 
assay. 
 
Pilot screen for optimization of screening stringency 
Prior to the library screen, Dualsystems performed a series of pilot screens to 
identify optimal screening conditions, by monitoring background interaction and 
interaction with positive controls while varying amounts of 3-amino-1,2,4-triazole (3-
AT) to modulate the sensitivity of the HIS3 reporter gene. 
 
Library transformation and selection of interactors  
Dualsystems next screened their library of cDNAs from adult human brain in the 
pPR3-N vector (in the NubG-x conformation, with the prey fused to the 3’ end of NubG).  
The library contains approximately 2.0 x 106 independent clones, with average insert size 
1.7 kb.  Yeast reporter strain NMY32 expressing our bait were sequentially transformed 
with prey clones, and primary selection was performed via growth assay on trp-leu-his-
ade- dropout media.   
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-galactosidase activity assay 
Putative positive interactors from the primary growth assay were further studied via 
high-throughput -galactosidase assay for the expression of lacZ.  Briefly, yeast cultures 
were grown to late exponential phase, pelleted, and resuspended in lysis buffer plus X-gal 
substrate.  Color development was monitored over time. 
 
Plasmid recovery and retransformation in E. coli 
Prey plasmids with the highest levels of -galactosidase activity were isolated from 
the primary yeast clones (in duplicate for each hit) and amplified in E. coli. Restriction 
digests using SfiI were performed to determine insert size. If both plasmids isolated from 
a given primary clone were identical in size, one plasmid was processed further. If two 
different sizes were noted (suggesting that the yeast cell may have taken up multiple prey 
plasmids during transformation), both plasmids were further processed. 
   
Confirmation of positive interactors 
After plasmid purification, each vector was reintroduced into the reporter strain 
expressing the bait (in parallel with yeast expressing an empty vector control bait), and 
the transformants were each retested for growth on selective media and for -
galactosidase activity. The clones that demonstrated reproducible signs of interaction 
with KCNE4 were then sequenced at the junction between NubG and the cDNA to 
determine the reading frame and to identify the encoded protein by BLAST analysis. 
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Results 
 
Biochemical validation of KCNE4 bait 
After cloning KCNE4 into the bait vector pBT3-STE, we made a few attempts to 
validate its expression in yeast by Western blot but as advised by Dualsystems we did not 
apply major efforts toward optimization. Dualsystems reports that they typically detect 
only 10-20% of all baits by Western blot due to any of a number of possible limitations, 
including low expression in yeast due to the weak Cyc1 promoter, limited solubility of 
the protein, or non-specific proteolytic activity. Dualsystems relies much more heavily on 
the functional validation assays for assessing whether a bait construct is properly 
expressed and can be used in a library screen. 
The results of our biochemical validation studies are found in Figure 12. Following 
SDS-PAGE and immunoblot, the KCNE4 fusion protein should be detectable with a 
molecular weight of approximately 60 kDa. A band of this size is apparent in both the 
anti-KCNE4 and anti-LexA blots, but the identity of this band is unclear without 
additional analysis via blocking peptides, a blot probed with secondary antibody alone, or 
a parallel blot of lysates from non-transfected yeast, none of which we performed. Protein 
lysates from yeast transfected with pCCW-Alg5 and pPR3-N served as a positive and 
negative control, respectively, for the LexA antibody. The Alg5-Cub-LexA-VP16 fusion 
protein should be detectable with anti-LexA and has predicted molecular weight of 77.5 
kDa; pPR3-N does not express any proteins that should be detectable in an anti-LexA 
blot. A band slightly smaller than 75 kDa unique from the bands in the other lanes was 
detectable in the pCCW-Alg5 lane and could represent the control bait. 
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Figure 12. Biochemical validation of bait expression in yeast. A, Anti-
KCNE4 immunoblot (IB) in protein lysates from yeast transformed with 
pBT3-STE-KCNE4. B, Anti-LexA immunoblot in protein lysates from yeast 
transformed with pBT3-STE-KCNE4, pCCW-Alg5, or pPR3-N. Arrows 
indicate putative bands of interest.
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Functional validation of KCNE4 bait 
We relied instead on a functional assay, the “NubG/NubI” test, for ultimate 
validation of correct expression of the bait. This assay revealed that co-expression of our 
KCNE4 bait with the NubI control prey yielded robust growth of white yeast colonies on 
trp-leu-his- and trp-leu-his-ade- plates (100% and 62% of growth on non-selective trp-
leu- plates, respectively), suggesting that the bait was properly expressed with the Cub-
LexA-VP16 complex in the cytosol, and split ubiquitin was reconstituted leading to the 
transcription of HIS3 and ADE2 (Table 2). Further, co-expression of our KCNE4 bait 
with the NubG control prey yielded little growth on the selective plates (22% and 13 % of 
growth on non-selective plates), suggesting that our bait is not self-activating and NubG 
must be tethered to a KCNE4 interacting partner for transcription of HIS3 and ADE2. The 
results of this assay gave us confidence to proceed with our library screen so we provided 
Dualsystems with our KCNE4 bait construct.  
Dualsystems performed additional functional validation assays using our KCNE4 
bait. They reported that our bait was negative for self-activation in yeast strain NMY32 
as observed via studies of adenine and histidine prototrophy and by an assay of -
galactosidase activity (data not shown). Further, growth assays following co-
transformation of NMY32 with our KCNE4 bait and a panel of control prey clones show 
robust growth of white yeast colonies upon co-expression of our KCNE4 bait with 
plasma membrane-bound control prey clones tethered to NubI but not NubG (Figure 13). 
Finally, Dualsystems reported that the optimal screening conditions for our bait include 
selection on trp-leu-his-ade- media with 20 mM 3-AT, as was indicated by a pilot screen. 
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trp-leu-his- trp-leu-his-ade- trp-leu-
bait prey # colonies (%) # colonies (%) # colonies
KCNE4-Cub Alg5-NubI     (+ control) 722 (>100) 340 (62) 548
KCNE4-Cub Alg5-NubG    ( - control) 131 (22) 80 (13) 600
Alg5-Cub     
(+ control)
Alg5-NubI     
(+ control) 300 (71) 356 (84) 424
Alg5-Cub     
(+ control)
Alg5-NubG    
( - control) 100 (29) 268 (78) 344
Table 2. Results of functional validation assay with KCNE4-Cub bait construct.  
For each of four co-transformations, number and percentage of colonies counted four 
days after plating as indicated for selective (trp-leu-his- and trp-leu-his-ade-) versus 
non-selective (trp-leu-) media.
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Figure 13. Functional validation of pBT3-Ste-KCNE4 bait by co-transformation 
with control prey plasmids. Panels show representative growth of yeast on selective 
(trp-leu-ade- or trp-leu-his-) versus non-selective (trp-leu-) media following co-
transformation with the bait and prey plasmids indicated.  Data provided by Dualsystems
Biotech.
48
Library screen 
We requested that Dualsystems screen our KCNE4 bait with their human adult 
brain cDNA library because human adult heart was not available, and as an excitable 
tissue, brain seemed to be the most appropriate option among the alternatives. We 
anticipated that many of the KCNE4 interacting partners identified by screening an adult 
brain cDNA library would be proteins that might perform similar functions in a cardiac 
myocyte and have corresponding relevance to the function of KCNE4. In the library 
screen, Dualsystems reported that the transformation efficiency was 9.5 x 104 cfu/g 
DNA.  In total, they screened 2.7 x 106 transformants and identified 108 putative 
interactors by a primary growth assay on trp-leu-his-ade- media. Those 108 clones were 
then tested in a high throughput assay for -galactosidase activity, which indicated that 
98 of the clones were also positive for lacZ expression (Figure 14). 
 
Analysis of putative interactors 
We selected 20 clones that appeared to be strong interactors (based on qualitative 
assessment of the intensity of blue color in Figure 14) for follow-up analysis.  In 
duplicate for each prey clone, Dualsystems isolated the plasmids, amplified each in E. 
coli, and performed a restriction digest using SfiI to assess the size of each insert.  For 
each prey clone except two (14 and 28), the duplicate samples yielded inserts of identical 
size (Figure 15), suggesting that the yeast cells responsible for those clones had been 
transformed with just one prey clone each.  Two separate plasmids were recovered each 
from clones 14 and 28, and these were handled independently going forward, bringing 
the total number of putative positive prey clones for further analysis to 22.   
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1 hour:
24 hours:
Figure 14. Results from -Galactosidase assay in 108 putative positive prey 
clones. Development of blue color indicates -galactosidase activity and reflects 
strength of the bait-prey interaction. Images captured 1 hour (top) and 24 hours 
(bottom) after adding X-Gal substrate to yeast lysates. Red circles indicate twenty 
clones selected for further analysis. Legend provides ID number assigned to each 
clone as used in subsequent figures. Data provided by Dualsystems Biotech.
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Figure 15. Prey plasmid insert sizes following SfiI digestion. Plasmids from 
each prey clone run in duplicate and identified by numbers above gel lanes. Marker 
sizes indicated in base pairs. Data provided by Dualsystems Biotech.
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To confirm the interaction between each of the prey constructs and our KCNE4 
bait, Dualsystems next co-transformed yeast with our bait plus each of the 22 prey clones 
isolated following the screen and repeated the growth and -galactosidase assays. Figure 
16 illustrates results of the growth assay, comparing yeast growth on non-selective versus 
selective media following co-transformation of NMY32 with either our KCNE4 bait or a 
control empty bait vector p415CYC plus each of the 22 prey clones. Each prey conferred 
histidine prototrophy to yeast transformed with our KCNE4 bait (compared with no 
growth on trp-leu-his- dropout media when co-transformed with the control bait, which 
suggests that none of the prey clones is self-activating). The change in color of the yeast 
colonies from red to white upon coexpression with KCNE4 bait suggests each prey also 
activates the ADE2 gene, although observable growth on trp-leu-his-ade- dropout media 
was only evident for four of the prey clones (28-1, 36, 78, and 95). Results of the repeat 
-galactosidase assay (Figure 17) also confirm expression of lacZ for all prey clones 
except one (79) when coexpressed with KCNE4 bait (but no lacZ expression when 
coexpressed with the empty vector control bait). From this set of assays, Dualsystems 
concluded that all of our selected prey clones gave reproducible signs of interaction with 
KCNE4 except clone 79. 
Finally, the insert sequence of each prey clone was determined, and BLAST 
analysis revealed the identity of the parent genes (Table 3). The insert sequences were 
between 1211 and 1274 base pairs long, and 20 out of 21 each matched a human mRNA 
sequence with at least 97 % identity over a span of 520 to 1102 base pairs (one prey, 84-
2, matched only a human BAC clone with no associated gene).  The 20 identified prey 
proteins included 5 membrane-associated proteins (MBP, PDZD11, ANXA5, CALM2, 
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Figure 16. Repeat growth assay for interaction between KCNE4 bait and 22 
select prey clones. Images of yeast colonies following co-transformation with 
indicated prey plus either KCNE4 or control bait (p415CyC), grown on non-
selective versus selective media. Data provided by Dualsystems Biotech.
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Figure 17. Repeat -galactosidase assay for interaction between 
KCNE4 bait and 22 select prey clones. Accumulation of blue color 
reflects activation of MbYTH reporter gene lacZ in yeast co-transformed with 
each prey plus KCNE4 bait (versus empty bait control p415Cyc).
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prey ID accession #
gene 
symbol gene name
% 
Identity
length of hit 
(bp)
04-2 NM_198261.2 RSRC2 arginine/serine-rich coiled-coil 2 97 1080
11-1 NM_001154.2 ANXA5 annexin A5 98 1105
14-1 NM_001025101.1 MBP myelin basic protein 98 1047
14-2 NM_000320.1 QDPR quinoid dihydropteridine reductase 97 1018
26-2 NM_004522 KIF5C kinesin family member 5C 98 1107
28-1 NM_001860.2 SLC31A2 solute carrier family 31 (copper transporters), member 2 98 1062
28-2 NM_01434.1 MTCH1 mitochondrial carrier homolog 1 97 699
31-1 NM_002567.2 PEBP1 phosphatidylethanolamine binding protein 1 100 823
36-1 NM_016484.3 PDZD11 PDZ domain containing 11 99 951
37-2 NM_005760.2 CEBPZ CCAAT/enhancer binding protein zeta 98 1102
38-2 NM_182935.2 MOBP myelin-associated oligodendrocyte basic protein 100 810
53-1 NM_005471.3 GNPDA1 glucosamine-6-phosphate deaminase 1 98 1069
67-1 NM_000365.4 TPI1 triosephosphate isomerase 1 98 1006
70-2 NM_030593.1 SIRT2 sirtuin 2 99 989
72-1 NM_032823.3 C9orf3 chromosome 9 open reading frame 3 98 1032
78-2 NM_001428.2 ENO1 enolase 1 98 1087
81-2 NM_001517.4 GTF2H4 general transcription factor IIH, polypeptide 4 98 890
84-2 AC104791.3  --- BAC clone RP11-181K12 from 4 99 985
95-1 NM_001743.3 CALM2 calmodulin 2 97 1078
106-2 NM_014235.2 UBL4A ubiquitin-like 4A 100 520
108-1 NM_006070.4 TFG TRK-fused gene 98 795
Table 3. Results of BLAST analysis revealing identity of 21 prey clones that 
yielded reproducible signs of interaction with KCNE4 bait.
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SLC31A2), 11 cytoplasmic proteins (KIF5C, QDPR, TFG, PEBP1, ENO1, TPI1, 
MTCH1, MOBP, GNPDA1, C9orf3, UBL4A), 3 nuclear proteins (GTF2H4, SIRT2, 
CEBPZ), and 1 protein of unknown localization (RSRC4).  Table 4 includes a brief 
description of known functional characteristics for each protein. 
 
Discussion 
We successfully employed MbYTH to identify 21 putative interacting partners of 
KCNE4. The set of interacting proteins identified did not include any KV channels as we 
had hoped, in order to identify novel targets of modulation by KCNE4. The lack of KV 
channels among the screening hits carries a number of potential implications for our 
understanding of the function of KCNE4, including the possibility that 1) KCNE4 
doesn’t function as a KV channel modulator in brain, or that 2) KCNE4 doesn’t modulate 
KV channels via direct interaction with the channel  subunit, and instead exerts its effect 
on channels via intermediate proteins. 
Fortunately, identification of non-KV channel protein interacting partners can 
provide useful leads toward understanding other aspects of the function of KCNE4 – for 
example, its trafficking, its regulation, and potential cellular functions beyond direct 
modulation of channel activity. Based on their known functions, a number of the hits 
have more obvious potential for intersection with KCNE4.  For example, calmodulin is a 
known modulator of voltage-gated ion channels including KCNQ127,28,126-129.  The 
interaction between KCNQ1 and calmodulin has so far been studied without considering 
implications for KV channel accessory subunits. To begin investigating a potential 
interaction between KCNE4 and calmodulin, we can use previous characterizations of the 
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gene 
symbol gene name protein type remarks
RSRC2 arginine/serine-rich coiled-coil 2 uknown unknown function
ANXA5 annexin A5 channel-like phospholipase A2 and protein kinase C inhibitory protein with calcium channel activity
MBP myelin basic protein secreted protein
major constituent of the myelin sheath in oligodendrocytes and 
Schwann cells; also expressed in bone marrow and immune system
QDPR quinoid dihydropteridine reductase enzyme
catalyzes NADH-mediated reduction of quinonoid dihydrobiopterin.  
Essential component of the pterin-dependent aromatic amino acid 
hydroxylating systems
KIF5C kinesin family member 5C motor protein member of kinesin 1 family of motor proteins which transport specific cargoes along the microtubules; substrate of protein kinase CK2
SLC31A2 
or  CTR2
solute carrier family 31 (copper transporters), 
member 2 or  copper transporter 2 transporter copper transporter 
MTCH1 or 
PSAP
mitochondrial carrier homolog 1 or  presenilin 
1-associated protein
integral 
mitochondrial 
membrane
integral mitochondrial outer membrane protein; interacts with 
presenilin 1; induces apoptosis when overexpressed in cultured cells
PEBP1 or 
RKIP
phosphatidylethanolamine binding protein 1 
or  Raf-1 kinase inhibitor protein
kinase 
inhibitor
modulates signaling in the MAP kinase cascade; metastasis 
suppressor
PDZD11 or 
PISP
PDZ domain containing 11 or  plasma 
membrane calcium ATPase-interacting single 
PDZ protein
modulator of 
membrane 
transporters
ubiquitously expressed; previously shown to modulate Ca-ATPase and 
Menkes copper ATPase
CEBPZ or 
CBF
CCAAT/enhancer binding protein zeta or 
CCAAT binding protein DNA binding transcriptional regulator
MOBP myelin-associated oligodendrocyte basic protein structural
soluble cytoplasmic protein which is important for stabilization of 
compact myelin
GNPDA1 glucosamine-6-phosphate deaminase 1 enzyme catalyzes the reversible conversion of glucosamine-6-phosphate into D-fructose-6-phosphate (Fru6P) and ammonium
TPI1 triosephosphate isomerase 1 enzyme
catalyzes the isomerization of glyceraldehydes 3-phosphate (G3P) and 
dihydroxy-acetone phosphate (DHAP) in glycolysis and 
gluconeogenesis
SIRT2 sirtuin 2 DNA binding class III histone deacetylase implicated in control of mitotic exit
C9orf3 chromosome 9 open reading frame 3 enzyme member of the M1 zinc aminopeptidase family; catalyzes the removal of an amino acid from the amino terminus of a protein or peptide
ENO1 or 
MBP-1
enolase 1 or  c-myc promoter binding protein 
1 enzyme
glycolytic enzyme; short form (MBP-1) exhibits transcriptional 
repressor activity
GTF2H4 general transcription factor IIH, polypeptide 4 DNA binding general transcription factor, component of the preinitiation complex
 --- BAC clone RP11-181K12 from 4  ---  ---
CALM2 calmodulin 2 calcium sensor member of the EF-hand calcium-binding protein family
UBL4A ubiquitin-like 4A chaperone part of protein complex that facilitates targeting of tail-anchored proteins to the TRC40 insertion pathway
TFG TRK-fused gene fusion protein member of NF-kappaB pathway; target of translocations in lymphoma and thyroid tumors; normal cellular role is unclear
Table 4. Functional characteristics of putative KCNE4 interacting partners identified in 
MbYTH screen.
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functional interaction between calmodulin and KCNQ1 as a starting point for formulating 
hypotheses. Experiments designed to characterize the biochemical and functional 
interaction between KCNE4 and calmodulin are discussed in Chapter III.  
Similarly, we can speculate about the relevance of a potential interaction between 
KCNE4 and any of the other MbYTH hits based on their known functions, though the 
degree to which an apparent connection to KCNE4 already exists varies considerably 
among them. The appearance of several transcription factors among the hits is interesting 
in light of a previous study which described the ability of a C-terminal fragment of the 
voltage-gated calcium channel CaV1.2 to translocate to the nucleus and regulate 
expression of a number of genes through its interaction with other nuclear proteins130. A 
similar function is conceivable for KCNE4, especially since it has a long C terminus 
(unique among the KCNE proteins), the importance of which is not known. Alternatively, 
this long C terminus could promote the interaction of KCNE4 with any of the 
cytoplasmic proteins among the MbYTH hits, whether implicated in enzymatic reactions, 
signaling cascades, or other cellular functions. 
A number of experimental limitations must be considered in our application of the 
MbYTH screen to identify novel KCNE4 protein interacting partners and learn more 
about its native physiologic function. MbYTH screening is most greatly limited by the 
inability to create a truly comprehensive, functional library of cDNA prey fused to NubG.  
When constructing the library, only one-third of the inserted cDNAs will be in-frame at 
their 3’ end with NubG, and only a fraction of those in-frame cDNAs will be full-length.  
Additionally, in our MbYTH screen, which used a “NubG-x” prey library, we were 
unable to identify type I integral membrane proteins (with extracellular N-termini, such 
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as other KCNE proteins) that might interact with KCNE4. We may wish to eventually 
screen x- NubG cDNA libraries to expand our coverage to include type I integral 
membrane proteins, but these libraries present separate technical challenges. Together, 
these factors limit the sensitivity of the MbYTH screen at picking up all KCNE4 
interacting partners.  
Additionally, this screen can be assumed to carry a high rate of false positives, due 
to the possibility of self-activating bait or prey clones, or non-specific aggregation of bait 
and prey that allows reconstitution of split ubiquitin. Finally, it is important to consider 
that not all protein-protein interactions that occur in transformed yeast will reflect 
important protein-protein interactions that take place endogenously in mammalian cells. 
 Despite these limitations, the screen was a useful tool for identifying putative 
protein interacting partners of KCNE4, and has provided us with many new leads for 
investigating the native physiologic function of KCNE4. To pursue any of the interaction 
partners further, important next steps include validating the biochemical interaction then 
assessing its functional importance.  We pursued further characterization of the 
interaction between KCNE4 and calmodulin by applying these steps, and our findings are 
described in Chapter III. 
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CHAPTER III 
 
KCNE4 JUXTAMEMBRANE REGION IS REQUIRED FOR INTERACTION WITH 
CALMODULIN AND FOR FUNCTIONAL SUPPRESSION OF KCNQ1 
 
 
 
Regulation of many voltage-gated potassium (KV) channels occurs through a variety 
of intracellular second messengers and by interactions with accessory subunits. Several 
KV channels, including KCNQ1 (KV7.1), are modulated by accessory subunits belonging 
to the KCNE family of single-transmembrane domain proteins70,131,132. KCNE1 associates 
with KCNQ1 to form the channel complex responsible for generating the slow 
component of the cardiac delayed rectifier current (IKs). IKs is a repolarizing K+ current 
critical during later phases of the cardiac action potential2,3 that is impaired in various 
genetic or acquired cardiac arrhythmia syndromes42,133-137 arising from mutations in the 
genes encoding either KCNQ1 or KCNE1. 
In some circumstances, accessory subunits are required for transducing intracellular 
signaling events into physiologically relevant changes in KV channel activity. For 
example, in the heart KCNQ1 is modulated by -adrenergic signaling through cAMP-
mediated channel phosphorylation. However, this effect results in physiological changes 
in potassium current only when certain KCNE subunits are also expressed138,139. 
Elucidating other functional and biochemical events that accompany KCNE modulation 
of KV channels is important for understanding the physiological importance of this 
accessory subunit family. 
A comprehensive understanding of KCNQ1 regulation by KCNE proteins may 
require that we consider properties of these interactions in the context of the relevant 
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intracellular milieu such as the cycling of internal Ca2+ concentration that occurs in 
cardiac myocytes. Each ionic component of the cardiac action potential including IKs is a 
potential target for feedback regulation by intracellular Ca2+. Indeed, calmodulin (CaM), 
the ubiquitous Ca2+-transducing protein28,140, is recognized to bind and confer Ca2+ 
sensitivity to the biophysical properties of several cardiac ion channels including 
KCNQ127,28,141-144. Of note, KCNQ1 interacts biochemically with CaM through a domain 
in the channel carboxyl-terminus, and pharmacological disruption of the KCNQ1-CaM 
interaction causes complete suppression of KCNQ1 current, suggesting that CaM is 
required for KCNQ1 activity27,28. In this study, we asked whether certain KCNE 
accessory subunits might interact biochemically or functionally with CaM.  Specifically, 
because the dramatic inhibitory modulation of KCNQ1 by KCNE4 resembles the effect 
of disrupting the binding of CaM to KCNQ1, we hypothesized that an interaction 
between KCNE4 and CaM could be involved in the modulation of KCNQ1 by KCNE4. 
This hypothesis is supported by work described in Chapter II. 
Our results demonstrate that KCNE4, but not KCNE1, can biochemically interact 
with CaM and that this interaction requires a tetra-leucine motif in the juxtamembrane 
region of the KCNE4 carboxyl-terminus. Further, mutation of this tetra-leucine motif 
abolishes CaM association with KCNE4 and impairs functional interactions of KCNE4 
with KCNQ1.  Our findings have potential relevance to KCNQ1 regulation by an 
important and ubiquitous intracellular signaling molecule. 
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Methods 
 
cDNA constructs 
Full-length KCNQ1 was expressed from the pIRES2-DsRed vector, whereas  
KCNE1 and KCNE4 were subcloned into pIRES2-EGFP (Clontech), as described 
previously70. A triple HA epitope (YPYDVPDYAGYPYDV PDYAGSYPYDVPDYA) 
was introduced into the KCNE4 vector, and a triple FLAG epitope 
(DYKDHDGDYKDHDIDYKDDDDK) into the KCNE1 cDNA, immediately upstream 
of the stop codon. HA sequence was PCR amplified from a plasmid provided by Sabina 
Kupershmidt (Vanderbilt University, Nashville, TN, USA); FLAG sequence was PCR 
amplified from p3XFLAG-CMV™-13 (Sigma-Aldrich). Addition of the epitope tags did 
not affect the modulatory properties of KCNE4 or KCNE1, as previously reported52. 
Point mutations were engineered using QuikChange Mutagenesis (Stratagene). All 
constructs were verified by complete sequencing of the open reading frames.   
 
Cell culture and transfection 
Chinese hamster ovary cells (CHO-K1, American Type Culture Collection) were 
grown at 37°C with 5% CO2 in F-12 nutrient mixture medium supplemented with 10% 
fetal bovine serum (FBS, Atlanta Biologicals), penicillin (50 units ml−1)–streptomycin 
(50 μg ml−1) and L-glutamine (2 mM). CHO cells stably expressing KCNQ1 or KCNQ1 
plus KCNE1 were generated using transposon-mediated gene transfer145. Stable clones 
were identified by G418 resistance and tested by patch-clamp recording, and maintained 
at 37°C with 5% CO2 in CHO cell medium plus 600 g/ml G418. Unless otherwise 
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stated, all tissue culture media were obtained from Invitrogen. CHO cells were transiently 
transfected using FuGENE-6 (Roche Applied Science). For electrophysiology studies 
shown in Figure 25, cells were transfected with a 2:1 ratio of KCNQ1 to E4-HA, L[69-
72]A-HA, or empty vector DNA. 
 
Protein isolation 
Forty-eight hours post-transfection, CHO cells were lysed for recovery of protein as 
previously described52. Briefly, one 100 mm dish of cells for each transfected construct 
was washed twice with ice-cold phosphate buffered saline (PBS) (137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4), then lysed with NP-40 lysis buffer (1% 
NP-40, 150 mM NaCl, 50 mM Tris, pH 8.0) supplemented with Complete mini protease 
inhibitor tablet (Roche Applied Science). Lysates were rocked for 30 min at 4°C then 
centrifuged twice at 14,000 x g for 10 min to remove insoluble debris. Total protein 
concentration was quantified using a Bradford reagent (Bio-Rad Laboratories). 
 
Peptides 
CaM-inhibitory peptides CaMKII-P, LKKFNARRKLKGAILTTMLA (Enzo Life 
Sciences) and MLCK-P, RRKWQKTGHAVRAIGRL, and control peptide CTRL-P, 
RRKEQKTGHAVRAIGRE (CalBiochem) were used in biochemical and functional 
experiments in Figures 18, 19 and 22. In a previous characterization of MLCK-P (“Trp 
peptide”), the Kd of calmodulin and MLCK-P was calculated to be 6 pM from assay of 
MLCK inhibition, yielding the conclusion that the peptide inhibits MLCK by trapping 
calmodulin and leaving free calmodulin concentration very low146. Similarly, prior 
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characterization of CaMKII-P (“peptide 290-309”) determined that CaMKII-P inhibits 
CaMKII and CaM-dependent phosphodiesterase activity by peptide interaction with CaM 
and not by a direct effect on the enzyme 147. Our experiments in Figures 18, 19 and 22 
make use of the ability of these peptides to bind CaM and induce its dissociation from 
KCNQ1 or KCNE4. CTRL-P is an analog of MLCK-P with two amino acid substitutions 
that disrupt its interaction with CaM146. 
 
CaM-agarose pull-down 
Cellular lysate (100 g) was added to 50 L CaM-agarose beads slurry (Sigma-
Aldrich) in 1.7 ml microcentrifuge tubes, and volume was brought to 0.5 ml with wash 
buffer consisting of NP-40 lysis buffer with protease inhibitors and either 2 mM CaCl2 or 
2 mM EGTA + 2 mM EDTA. Protein was incubated with beads for 2 h at 4°C with 
rocking, in the presence or absence of CaM-inhibitory peptides CaMKII-P, MLCK-P, or 
CTRL-P. Beads were pelleted and supernatant was reserved as unbound fraction. Beads 
were washed six times in 1 ml CaCl2 or EGTA + EDTA wash buffer, then resuspended in 
25 l 2x SDS-PAGE sample buffer (100 mM Tris pH 7.5, 20% glycerol, 4% Na dodecyl 
sulfate, 0.008% bromophenol blue, 5% -mercaptoethanol, 5 M urea). Proteins were 
eluted from beads by heating for 5 min at 95°C.   
 
Preparation of cross-linked antibody 
As previously described 52, 10 g of antibody were combined with 750 μl of borate 
buffer (200 mM sodium tetraborate decahydrate, pH 9.0), and 50 μl of Protein-G 
Sepharose™ 4 Fast Flow (GE Healthcare) and rocked at room temperature for 1 h. The 
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beads were washed with borate buffer supplemented with 20 mM dimethyl pimelimidate 
dihydro-chloride, and rocked for 30 min at room temperature. The cross-linking reaction 
was quenched by 1 h incubation with 200 mM ethanolamine, pH 8.0. Beads were washed 
in PBS and stored at 4°C until use. 
 
Co-immunoprecipitation 
Cellular lysates were pre-cleared with Protein-G Sepharose™ 4 Fast Flow then 
incubated for 1 h at 4°C with 50 l cross-linked antibody. Beads were washed three times 
in ice-cold lysis buffer plus protease inhibitors, then proteins were eluted with 2X SDS-
PAGE sample buffer for 5 min at 55 °C. 
 
Cell-surface biotinylation 
Forty-eight hours after transfection, CHO cells were bathed in 1.5 mg·ml−1 sulfo-
NHS-biotin (Pierce Chemical Company) in PBS for 1 h on ice. The biotinylation reaction 
was quenched with 100 mM glycine in PBS, then cellular lysates were prepared as 
described above, in ice-cold RIPA buffer (150 mm NaCl, 50 mm Tris-Base, pH 7.5, 1% 
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, supplemented with a Complete mini-
protease inhibitor tablet). Lysates were incubated with ImmunoPure Immobilized 
Streptavidin beads (Pierce Chemical Co.) overnight at 4°C. Beads were pelleted and the 
supernatant was reserved as the non-biotinylated fraction. Beads were washed three times 
then biotinylated proteins were eluted in 2x SDS-PAGE sample buffer for 30 min at room 
temperature.  
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SDS-PAGE and Western blotting 
Protein samples were subjected to electrophoresis on pre-cast 4-20% Tris-HCl gels, 
then transferred to Immun-Blot™ PVDF membranes (Bio-Rad Laboratories). Membranes 
were blocked for one hour with 10% non-fat dry milk in TBS-T before applying the 
appropriate primary antibody in 4% non-fat dry milk in TBS-T: 1:5000 mouse 
monoclonal anti-HA (Covance), 1:200 goat polyclonal anti-KCNQ1 (Santa Cruz 
Biotechnology), 1:2000 mouse monoclonal anti-calmodulin (Millipore Corporation), or 
1:1000 rabbit polyclonal anti-calnexin (Sigma). Membranes were washed in TBS-T then 
probed with the appropriate secondary antibody in 4% non-fat dry milk in TBS-T: 1:5000 
goat anti-mouse IgG-HRP, rabbit anti-goat IgG-HRP, or goat anti-rabbit IgG-HRP (Santa 
Cruz). Membranes were washed in TBS-T and HRP signal was detected using ECL Plus 
(GE Healthcare Life Sciences) and Kodak BioMax MS film (Kodak). For E4-HA pull-
down by CaM-agarose in the presence of CaM-inhibitory peptides, protein band 
densitometry was performed on scanned films using ImageJ software (National Institutes 
of Health). Differences among groups were determined by one-way ANOVA, with 
Tukey post-test for pairwise comparison. 
 
Electrophysiology 
Currents were measured in CHO cells using the broken-patch, whole-cell 
configuration of the patch clamp technique148. For experiments using transiently co-
transfected cells, only yellow fluorescent cells (positive for both dsRed-MST and EGFP 
fluorescence) were recorded. Whole cell currents were recorded at room temperature 
(20–23°C) using Axopatch 200 and 200B amplifiers (MDS Analytical Technologies). 
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Pulses were generated using Clampex 8.1 (MDS Analytical Technologies), and whole 
cell currents were filtered at 1 kHz and acquired at 5 kHz. The access resistance and 
apparent membrane capacitance were estimated as previously described149. Whole-cell 
currents were not leak subtracted. Unless otherwise indicated, whole-cell currents were 
measured during a series of 2-s voltage steps from a holding potential of −80 mV to test 
potentials ranging from 80 to +60 mV (in 10-mV increments) followed by a 1-s step to 
30 mV to record tail currents. The extracellular solution contained (in mM): 132 NaCl, 
4.8 KCl, 1.2 MgCl2, 1 CaCl2, 5 glucose, and 10 HEPES, pH 7.4. The standard 
intracellular solution contained (in mM): 110 K+ aspartate, 1 CaCl2, 10 HEPES, 11 
EGTA, 1 MgCl2, and 5 K2ATP, pH 7.35. Pipette solution was diluted 5–10% to prevent 
activation of swelling-activated currents. For experiments using CaM-inhibitory peptides, 
50 M peptide was added to the diluted pipette solution. For experiments using varying 
concentrations of intracellular free Ca2+ (Figures 20 and 26), see Table 5 for composition 
of intracellular solution. We also tested the effects of including EDTA along with EGTA 
to the 30 nM [Ca+2]i  pipette solution (Figure 20) to control for non-specific effects of 
EDTA. Patch pipettes were pulled from thick-wall borosilicate glass (World Precision 
Instruments, Inc.) with a multistage P-97 Flaming-Brown micropipette puller (Sutter 
Instrument Co.) and heat polished with a Micro Forge MF 830 (Narashige). After heat 
polishing, the resistance of the patch pipettes was 2–5 MΩ in the standard solutions. As a 
reference electrode, a 2% agar bridge with composition similar to the control bath 
solution was used. Junction potentials were zeroed with the filled pipette in the bath 
solution. Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich. Data 
were collected for each experimental condition from at least three distinct transient 
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free [Ca2+]          
(nM)
CaCl2 
(mM)
EDTA 
(mM)
EGTA 
(mM)
3 0.42 11 0
10 1 0 11
30 2.67 0 11
30 (EGTA + EDTA) 2.67 11 11
100 5.67 0 11
Table 5. CaCl2 and chelator composition of pipette solutions for varying [Ca
2+]i
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transfections and analyzed using a combination of Clampfit (MDS Analytical 
Technologies), OriginPro 7 (OriginLab Corporation) and SigmaPlot 2000 (Systat 
Software, Inc.). Steady-state current at each test potential was measured 1.9 s following 
the voltage step, and current density was obtained by normalizing steady-state current to 
cell capacitance. Voltage-dependence of activation was determined by normalizing peak 
tail current for each test potential to the maximal value for each cell, and plotting 
normalized peak tail current versus voltage. Activation curves were fitted with a 
Boltzmann function to determine the voltage for half-maximal activation (V1/2) and slope 
(k). To analyze kinetics of activation, the current recorded between 0.075 s and 0.475 s 
after the voltage step to +60 mV was fitted with a single exponential function to 
determine the time constant, tau (). Statistical analyses were performed using SigmaStat 
2.03 (Systat Software, Inc.).  
 
Results 
 
KCNQ1 interacts biochemically and functionally with CaM 
To demonstrate that KCNQ1 interacts biochemically with CaM in our experimental 
system (i.e., heterologous expression in CHO cells), we used CaM-agarose beads to pull 
down KCNQ1 in the presence of either CaCl2 or the Ca2+ chelators EGTA and EDTA. 
KCNQ1 was immunodetected robustly in eluate from beads incubated in the presence of 
CaCl2 but less was detectable when the incubation was performed in the presence of Ca2+ 
chelators (Figure 18A). To examine the specificity of this finding, we performed pull-
down assays in the presence of CaCl2 plus either of two CaM-inhibitory peptides, 
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Figure 18. Biochemical and functional interaction between KCNQ1 and CaM.  A, 
Representative immunoblot (IB) following CaM-agarose pull-down using lysates from CHO cells 
transiently transfected with full-length KCNQ1 (Q1) or non-transfected cells (NT), performed in 
duplicate in the presence of 2 mM CaCl2 or 2 mM EDTA + 2 mM EGTA.  Bound (beads) and 
unbound (supernatant, s/n) fractions were each probed for KCNQ1 using anti-KCNQ1.  Bars below 
each lane indicate average bound-to-unbound signal ratio, normalized to CaCl2 condition from 
same experimental replicate.  Mean ± SEM for normalized ratios: EDTA + EGTA, 0.03 ± 0.02, n = 
3; ***, p < 0.001 versus CaCl2 by t-test.    B, Representative immunoblot following CaM-agarose
pull-down of KCNQ1 in the presence of 2 mM CaCl2 and CaMKII-P, MLCK-P, or CTRL-P at 
indicated concentrations in M. Bars below each lane indicate average bound-to-unbound signal 
ratio, normalized to no peptide condition from same experimental replicate.  Mean ± SEM for 
normalized ratios: CaMKII-P, 0.07 ± 0.06, n = 2; MLCK-P, 0.06 ± 0.04, n = 3; CTRL-P, 0.65 ± 0.16, 
n = 3; ***, p < 0.001 by Tukey post-test pairwise comparisons to no peptide following one-way 
ANOVA (p < 0.001).  C, Decay of steady-state whole-cell current over time recorded in CHO cells 
expressing KCNQ1 in the presence of 50 mM CTRL-P, 50 mM MLCK-P or no peptide in the 
pipette solution.  Left, average (± SEM) steady-state current for each sweep during 0.1 Hz-train of 
2-s depolarizations to +60 mV from holding potential 80 mV, each normalized to current recorded 
in same cell 60 s after obtaining whole-cell configuration; n = 4; p ≤ 0.05 for one-way ANOVA and 
Tukey post-test pairwise comparison of MLCK-P versus CTRL-P and MLCK-P versus no peptide.  
Right, representative current traces recorded at 100 s and 370 s, normalized to steady-state 
current recorded at 60 s. 
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CaMKII-P and MLCK-P (named according to the binding regions of calmodulin-
dependent kinase II and myosin light chain kinase, respectively), or a control peptide, 
CTRL-P. Compared to the peptide-free condition, both CaM-inhibitory peptides impeded 
pull-down of KCNQ1 by CaM-agarose, whereas CTRL peptide did not diminish the 
interaction (Figure 18B). 
We next examined the functional significance of the interaction between KCNQ1 
and CaM in CHO cells. We recorded whole-cell currents in CHO cells transiently 
transfected with KCNQ1, using the MLCK inhibitory peptide in the pipette solution to 
disrupt the biochemical interaction between KCNQ1 and CaM. In the presence of 50 M 
MLCK peptide, steady-state current amplitude decayed rapidly over time whereas cells 
dialyzed with 50 M CTRL or with no peptide showed minimal decay (Figure 18C). We 
also studied whether the CaM-inhibitory peptide has a functional effect on IKs, by 
recording whole-cell currents in CHO cells stably expressing KCNQ1 + KCNE1. Again, 
in the presence of 50 M MLCK peptide, steady-state current amplitude decayed rapidly 
over time whereas cells dialyzed with 50 M CTRL or with no peptide showed minimal 
decay (Figure 19). 
We also observed that KCNQ1 function is Ca2+-sensitive. Specifically, we observed 
no effect of varying [Ca2+]i on current density, but a shift toward more depolarized 
voltage-dependence of activation was observed at lower intracellular Ca2+ concentrations 
(Figure 20). Overall, our results demonstrate a Ca2+-dependent interaction of KCNQ1 
with CaM that is necessary for channel activity.  
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Figure 19. IKs is sensitive to CaM availability. Representative whole-cell currents 
recorded from CHO cells stably expressing IKs in the presence or absence of CaM-
inhibitory peptide in the pipette solution. Traces reflect currents at time intervals 
indicated following membrane rupture
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Figure 20. Q1 voltage-dependence of activation is modulated by low intracellular free 
calcium concentrations. A, Activation curves for CHO cells stably expressing Q1 recorded in 
the presence of 3 nM, 10 nM, or 30 nM [Ca2+]i buffered with chelators as indicated (n = 8). B, 
V1/2 measured in CHO cells stably expressing Q1 recorded with 3 nM, 10 nM, 30 nM, and 100 
nM [Ca2+]i, plotted against [Ca2+]i . Mean V1/2 ± SEM: 3 nM -6.5 ± 0.7 mV, n = 8; 10 nM -4.7 ± 1.9 
mV, n = 8; 30 nM -14.5 ± 0.9 mV, n = 8; 30 nM (EGTA + EDTA) -16.8 ± 0.9, n = 8; p<0.001 by 
ANOVA and ***, p<0.001 for Tukey post-test pairwise comparison. C, Mean ± SEM current 
density versus voltage recorded in CHO cells stably expressing Q1 measured in the presence of 
3 nM, 10 nM, 30 nM and 30 nM (EGTA + EDTA) [Ca2+]i.  No trend in current density is observed 
with varying [Ca2+]i (n = 8).
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Ca2+-dependent interaction of KCNE4 with CaM 
The suppression of KCNQ1 current resulting from CaM inhibition closely 
resembles the effects of KCNE4 co-expression with the channel. We hypothesized that 
the mechanism of KCNQ1 inhibition by KCNE4 may involve the ability of KCNE4 to 
mimic a CaM inhibitory peptide. To test this hypothesis, we first sought to demonstrate 
interaction between KCNE4 and CaM.  
We used multiple biochemical approaches to assess whether KCNE4 can interact 
with CaM. First, CaM-agarose pull-down assays using lysates from CHO cells transiently 
transfected with epitope-tagged KCNE4 (KCNE4-HA) revealed that KCNE4-HA interacts 
with CaM in a Ca2+-dependent manner (Figure 21A). Next, we validated the biochemical 
interaction between KCNE4-HA and CaM by co-immunoprecipitation using an anti-CaM 
primary antibody. KCNE4-HA was detected following immunoprecipitation performed in 
the presence of CaCl2 but not Ca2+ chelators, whereas CaM was detectable in the 
immunoprecipitate regardless of Ca2+ availability (Figure 21B). Finally, we demonstrated 
that the interaction of KCNE4-HA with CaM could be significantly disrupted by CaM-
inhibitory peptides but not by the control peptide (Figure 22). These data indicate that 
KCNE4-HA and CaM biochemically interact in CHO cells. 
We also tested whether another KCNE subunit can interact biochemically with 
CaM by CaM-agarose pull-down using CHO cells transiently transfected with FLAG 
epitope-tagged KCNE1. No signal was detected in the bound fraction, regardless of 
whether the pull-down was performed in the presence of CaCl2 or Ca2+ chelators (Figure 
23). These results suggest that CaM interaction is not a universal property of all KCNE 
subunits. 
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Figure 21. Biochemical interaction between KCNE4 and CaM. A, Representative 
immunoblot following CaM-agarose pull-down using lysates from CHO cells transiently 
transfected with E4-HA or non-transfected cells (NT), performed in duplicate in the presence of 
2 mM CaCl2 or 2 mM EDTA + 2 mM EGTA.  Bound (beads) and unbound (s/n) fractions were 
each probed for KCNE4 using monoclonal HA antibody.  Bars below each lane indicate 
average bound-to-unbound signal ratio, normalized to CaCl2 condition from same experimental 
replicate.  Mean ± SEM for normalized ratios: EDTA + EGTA, 0.16 ± 0.09, n = 3; ***, p < 0.001 
versus CaCl2 by t-test.  B, Representative immunoblot following co-immunoprecipitation with 
anti-CaM in the presence of 2 mM CaCl2 or 2 mM EDTA + 2 mM EGTA.  The apparent higher 
molecular weight of apo-CaM versus holo-CaM following SDS-PAGE is consistent with 
previous findings20 and is attributable to conformational changes that allow CaM to adopt a 
more compact form upon binding Ca2+ 38.  Bars below each lane indicate average HA-to-CaM
signal ratio, normalized to CaCl2 condition from same experimental replicate.  Mean ± SEM for 
normalized ratios: EDTA + EGTA, 0.04 ± 0.06, n = 4; ***, p < 0.001 versus CaCl2 by t-test.
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Figure 22. CaM-inhibitory peptides disrupt KCNE4-CaM interaction. 
Representative immunoblot following CaM-agarose pull-down of E4-HA in the 
presence of CaMKII-P, MLCK-P, or CTRL-P at indicated concentrations in M.  
Pull-down performed in the presence of 2mM CaCl2. Bound (beads) and unbound 
(supernatant, s/n) fractions were each probed for KCNE4 using monoclonal anti-
HA. Bars below each lane indicate average bound-to-unbound signal ratio, 
normalized to no peptide condition. Mean ± SEM for normalized ratios: 50 M
CaMKII-P, 0.25 ± 0.05, n = 4; 5 M MLCK-P, 0.33 ± 0.11, n = 3; 16 M MLCK-P, 
0.41 ± 0.09, n = 3; 50 M MLCK-P, 0.24 ± 0.02, n = 4; 50 M CTRL-P, 0.76 ± 0.09, 
n = 4; ***, p < 0.01 for Tukey pairwise comparison to no peptide following one-way 
ANOVA (p = 0.001). 
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Figure 23. KCNE1 does not interact biochemically with CaM.  Representative 
anti-FLAG immunoblot following CaM-agarose pull-down using lysates from cells 
expressing KCNE1-flag or non-transfected cells, performed in duplicate in the 
presence of 2 mM CaCl2 or 2 mM EDTA + 2 mM EGTA.
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Juxtamembrane tetra-leucine motif is critical for KCNE4-CaM interaction 
To survey where CaM might interact with KCNE4 we examined the full-length 
KCNE4 amino acid sequence using an online CaM binding site prediction algorithm 
(http://calcium.uhnres.utoronto.ca). Based upon various peptide properties including 
hydropathy, -helical propensity, residue weight, side chain charge, and helical class, we 
identified one potential CaM interaction site located between KCNE4 residues 44 and 73. 
This candidate interaction site spans part of the transmembrane domain plus 15 residues 
of the adjacent intracellular juxtamembrane region of the KCNE4 carboxyl terminus 
(Figure 24A). Because critical binding energy in protein-protein interactions involving 
CaM is often provided by bulky hydrophobic amino acids150, we targeted a tetra-leucine 
motif (residues 69-72) within the candidate binding site for disruption of the interaction 
between KCNE4 and CaM. Specifically, we mutated the four leucine residues to alanines 
(designated L[69-72]A-HA), then performed CaM pull-down assays to determine effects 
on the protein-protein interaction. CaM-agarose assays comparing pull-down of wild-type 
KCNE4-HA to L[69-72]A-HA demonstrated that this juxtamembrane tetra-leucine motif is 
required for the biochemical interaction of KCNE4 with CaM (Figure 24B) most likely 
because this sequence is part of a CaM binding site. Importantly, this tetraleucine motif is 
conserved in KCNE4 orthologues across mammals, birds, and amphibians.  Similar 
motifs are absent in the other KCNE subunits and this is consistent with the observed 
lack of KCNE1 biochemical interaction with CaM (Figure 23).  
We also assessed CaM-agarose pull-down of E4-HA constructs engineered with 
charge reversals in the same region, R[62-63]E-HA and K[65-66]E-HA, and found that 
these mutations did not disrupt the biochemical interaction between KCNE4 and CaM 
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Figure 24. KCNE4 juxtamembrane tetra-leucine motif is critical for biochemical 
interaction with CaM.  A, Amino acid sequence of human KCNE4.  Box encloses predicted 
transmembrane domain, underline denotes region identified by online prediction tool 
(http://calcium.uhnres.utoronto.ca) as most likely to contain putative CaM binding site. B, 
Representative immunoblot following CaM-agarose pull-down comparing lysates from CHO 
cells transiently transfected with wild-type E4-HA, L[69-72]A-HA, or non-transfected cells (NT). 
Pull-down performed in the presence of 2 mM CaCl2. Bound (beads) and unbound (s/n) 
fractions each probed for KCNE4 using monoclonal anti-HA. Bars below each lane indicate 
average bound-to-unbound signal ratio, normalized to wild-type E4-HA from same experimental 
replicate.  Mean ± SEM for normalized ratios: L[69-72]A-HA, 0.12 ± 0.08, n = 3; ***, p < 0.001 
versus wild-type by t-test. C, Representative immunoblots following CaM-agarose pull-down 
comparing lysates from CHO cells transiently transfected with wild-type E4-HA, R[62-63]A-HA, 
K[65-66]E-HA, L[69-70]A-HA, L[71-72]A-HA, L[69-72]A-HA, L69A_L72A-HA, and L72A_L79A-HA. 
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(Figure 24C). Additionally, we generated E4-HA constructs with pairs of leucine-to-
alanine substitutions in the following combinations: L[69-70]A, L[71-72]A, 
L69A_L72A, and L72A_L79A. By CaM-agarose pull-down, it appears that none of these 
pairs of substitutions (except possibly L[69-70]A) is as effective at disrupting the 
KCNE4-CaM interaction as is substituting all four leucines in positions 69-72 with 
alanines (Figure 24C). 
 
Altered KCNQ1 modulation by L[69-72]A-HA 
To test whether disruption of the biochemical interaction between KCNE4 and CaM 
is accompanied by any functional consequences, we compared whole-cell currents 
recorded from CHO cells expressing KCNQ1 alone, KCNQ1 co-expressed with wild-
type KCNE4-HA, and KCNQ1 co-expressed with L[69-72]A-HA. Representative current 
traces and a current density-voltage plot illustrate that the dramatic KCNQ1 suppression 
normally exerted by wild-type KCNE4 is not evident with L[69-72]A-HA (Figure 25A & 
25B). The degree of KCNQ1 suppression was significantly less for L[69-72]A-HA than 
for wild-type KCNE4. Interestingly, L[69-72]A-HA exerts other modulatory effects on 
KCNQ1 including a significant shift in the voltage-dependence of activation curve to 
more depolarized potentials (Figure 25C; Table 6) and a significant slowing of the 
kinetics of activation (Figure 25D).   
It is important to note that cell-surface biotinylation assays revealed that L[69-
72]A-HA is detectable at the cell surface (Figure 25E), albeit at a reduced level. However, 
the modulatory effects of L[69-72]-HA on KCNQ1 described in Figure 25C and 25D 
imply that mutant KCNE4 subunits still associate with KCNQ1 at the plasma membrane 
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to a significant extent. Overall, these findings demonstrate that disrupting KCNE4-CaM 
interaction hinders the inhibition of KCNQ1 by KCNE4 and suggests possible 
mechanisms for the regulation of KCNQ1 function. 
 
KCNE4 inhibition of KCNQ1 is Ca2+-sensitive 
To assess whether KCNE4 inhibition of KCNQ1 is sensitive to [Ca2+]i, we 
compared whole-cell currents recorded from CHO cells stably expressing KCNQ1 and 
transiently transfected with KCNE4 or empty vector, measured using a pipette solution 
that contained either 10 nM or 3 nM free [Ca2+]. Representative current traces and a 
current density versus voltage plot (Figure 26) illustrate that KCNE4 fails to completely 
inhibit KCNQ1 current when [Ca2+]i is chelated acutely. CHO cells expressing KCNE4 in 
the absence of KCNQ1 generated no current when recorded using 3 nM [Ca2+] pipette 
solution, suggesting that the recorded currents illustrated in Figure 26 are not from 
endogenous channels activated by low [Ca2+]i (data not shown). These findings are 
consistent with the Ca2+ sensitivity of the biochemical interaction between KCNE4 and 
CaM (Figure 21A) and the impaired KCNQ1 inhibition by KCNE4 upon disrupting 
interactions between KCNE4 and CaM by mutagenesis. Importantly, the impairment of 
KCNE4 inhibition of KCNQ1 upon acutely chelating [Ca2+]i is unlikely explained by an 
acute decrease in KCNE4 cell-surface expression, favoring the interpretation that the 
KCNE4 function is directly affected by disrupting its interaction with CaM. 
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Figure 26.  KCNE4 inhibition of KCNQ1 is impaired upon reducing [Ca2+]i. 
A, Representative whole-cell currents from CHO cells stably expressing Q1 
and transiently transfected with empty vector or E4, recorded in the presence 
of 10 nM or 3 nM free [Ca2+].  B, Mean (± SEM) current density versus voltage 
plot (n = 8).  At all test potentials more positive than -20 mV, p < 0.05 for Q1 + 
GFP, 3 nM (∆) versus Q1 + E4, 3 nM (○) and p < 0.01 for Q1 + E4, 10 nM (●) 
versus Q1 + E4, 3 nM (○) by t-test.
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Discussion 
Regulation of KCNQ1 is physiologically important especially in heart where this 
protein constitutes the pore-forming subunit required to generate IKs, an essential 
repolarizing current. KCNQ1 is part of a macromolecular complex containing accessory 
subunits and regulatory proteins such as yotiao21, phosphodiesterase PDE4D3151 and 
CaM27,28. In addition to regulation by multiple intracellular second messengers including 
cAMP, PIP223,24, and Ca2+27,28,141,143,144, KCNQ1 is modulated by KCNE proteins, some 
of which can exert dramatic effects on the channel70,131.  
Interactions between accessory subunits (e.g., KCNE) and other regulatory proteins 
associated with the macromolecular IKs complex are emerging as another layer of 
complexity in regulating KCNQ1 function138. In this study, we uncovered a new and 
intriguing example of an interaction between a KCNE subunit and another important 
KCNQ1 regulatory protein. Specifically, we identified an interaction between KCNE4 
and CaM that is linked to the robust inhibitory effect of this accessory protein on 
KCNQ1. The observation that pharmacological inhibition of CaM dramatically blunts 
KCNQ1 activity27,28, which resembles the modulatory effect of KCNE4 on KCNQ1, 
prompted our hypothesis that KCNQ1 inhibition by KCNE4 could involve CaM.   
Our demonstration of a Ca2+-dependent biochemical interaction between KCNE4 
and CaM, and that KCNQ1 functional modulation by KCNE4 is impaired both upon 
mutation of a candidate CaM-interaction site in the juxtamembrane region of KCNE4 and 
by acutely chelating [Ca2+]i to displace CaM from KCNE4, suggests a connection 
between the mechanism of KCNQ1 inhibition by KCNE4 and the effect of CaM on the 
channel. We previously assumed that the inhibition of KCNQ1 by KCNE4 is caused by a 
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direct effect of KCNE4 on the channel48,152. In demonstrating that the interaction between 
CaM and KCNE4 is critical for the inhibitory effect of KCNE4, the data presented here 
introduce the new possibility that KCNE4 inhibits KCNQ1 by disrupting CaM-mediated 
KCNQ1 activation. 
The KCNE4 region we identified to be critical for its biochemical interaction with 
CaM lacks typical motifs shared by many (but not all) CaM-interacting proteins, such as 
an IQ domain or a 1-5-10 motif150. However, there are other examples of membrane 
proteins known to interact with CaM at an intracellular juxtamembrane region (as we 
demonstrated for KCNE4), including the epidermal growth factor receptor153-155. We 
previously demonstrated that the cytoplasmic domain of KCNE4 is necessary for its 
inhibition of KCNQ1, and is sufficient to confer inhibitory function to a chimera 
consisting of the N-terminus and transmembrane domain of KCNE1 but the C-terminus 
of KCNE448. This overlap between the CaM-binding site and the KCNE4 domain 
necessary for inhibition of KCNQ1 activity supports our hypothesis that KCNQ1 
inhibition by KCNE4 may involve its ability to interact with CaM. 
The primary structure of KCNE4 is distinct from the other four KCNE proteins at 
the juxtamembrane site identified here as a CaM-binding region. Specifically, the region 
containing four sequential hydrophobic leucine residues in KCNE4 is occupied by polar 
residues in the other four KCNE proteins, which would likely not support interactions 
with CaM. As we demonstrated in this study, KCNE1 does not interact with CaM when 
expressed alone (Figure 23). 
The identification of critical residues for CaM binding also allowed us to study the 
functional consequences of disrupting the KCNE4-CaM interaction. We demonstrated 
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that KCNE4 L[69-72]A subunits fail to robustly inhibit KCNQ1. However, expression of 
this KCNE4 mutant does modulate the kinetics and voltage-dependence of KCNQ1 
activation and changes kinetic properties of tail currents consistent with removal of 
inactivation (Figure 25). Overall these findings indicate that the mutant KCNE4 with 
impaired biochemical interaction with CaM also exhibits impaired ability to inhibit 
KCNQ1, whereas its ability to function as a modulatory subunit to KCNQ1 is not lost. 
We speculate that these residual functional effects of KCNE4 L[69-72]A on KCNQ1 
could be mediated through interactions between the pore-forming subunit and the 
KCNE4 transmembrane domain. In support of this notion, there are similarities in 
KCNQ1 modulation evoked by KCNE4 L[69-72]A and a chimera consisting of the N- 
and C-termini of KCNE1 coupled to the transmembrane domain of KCNE448. 
The physiological implications of the observations presented here may be 
significant, but are difficult to assign because of the primary lack of understanding of the 
physiological contributions of KCNE4. In heart, where KCNE4 could modulate 
repolarizing currents such as IKs, and where local free Ca2+ concentrations cycle 
dramatically, the Ca2+-CaM sensitivity described here for KCNE4 may enable Ca2+-
dependent regulation of repolarization time.  Because repolarization time is critical for 
action potential duration as well as Ca2+ release and contractility156, CaM-KCNE4 
interactions might constitute part of a feedback loop for regulating intracellular Ca2+. 
Further characterization of KCNE4 L[69-72]A in native cardiac myocytes will be 
valuable toward establishing the physiologic consequences of disrupting the interaction 
between KCNE4 and CaM. 
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The novel protein-protein interaction we demonstrated in this study reinforces the 
notion that KV channels function as dynamic protein complexes subject to regulation by 
both accessory subunits and intracellular signaling molecules, which may themselves 
interact to impact channel function. 
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CHAPTER IV 
 
INVESTIGATING THE PHYSIOLOGIC FUNCTION OF KCNE4 
 
Each of the five KCNE proteins modulates potassium channel function in a distinct 
manner, allowing specific transformation of the biophysical properties of a channel 
depending on which accessory subunit(s) is (are) present in the channel complex.  Given 
that the KCNE proteins can exert potent and diverse modulatory effects and may 
potentially participate in a large variety of channel complexes, a compelling question 
emerges:  what is the native physiologic role of each KCNE gene? 
The answer is partly revealed by the association of mutations in KCNE genes with 
inherited human diseases.  Specifically, mutations in KCNE1 have been associated with 
congenital long QT syndrome (LQTS)72,86,157, while KCNE2 variants have been identified 
in cases of sporadic and drug-induced LQTS72,84,87,88.  Periodic paralysis, a skeletal 
muscle disorder, has been associated with mutations in KCNE365,158.  Finally, deletion of 
a genomic region (Xq22.3) containing KCNE5 results in a syndrome featuring Alport 
syndrome, mental retardation, midface hypoplasia, and elliptocytosis55. 
These disease associations provide strong focus points for elucidating the 
physiologic roles of KCNE1, KCNE2, KCNE3, and KCNE5.  In the case of KCNE4, other 
than a single report159 that the minor allele of a SNP (1057 G/T) leading to a conservative 
amino acid substitution (145 E/D) is found slightly more frequently in patients with 
idiopathic atrial fibrillation than controls in a Chinese population (34.0% versus 27.1%, 
respectively), no human inherited disease has been associated with a mutation in KCNE4.  
89
Considering the particularly dramatic modulatory effects imparted by KCNE4 on critical 
channel complexes and the broad expression of KCNE4 by human tissues, it is likely that 
KCNE4 plays an important role in one or more physiologic systems, but we are left to 
investigate that role without the natural focus point arising from phenotypic 
characterization of native mutation carriers. 
An alternative approach to an investigation into the physiologic function of KCNE4 
is to first consider which tissues express KCNE4.  The mRNA expression pattern of 
KCNE4 (Figure 6, Chapter I) reveals that many tissues express KCNE4.  This set of 
tissues includes those whose functions are directly dependent on their ability to conduct 
electricity (such as heart, skeletal muscle, and brain) and some that are non-excitable 
(such as kidney, testes, and colon). 
KV channel complexes (including those comprised of KCNQ1 and KCNE subunits) 
have previously been implicated in critical physiologic functions in many of the tissues 
that express KCNE4.  As one example in a non-excitable cell type, data suggest that 
KCNQ1-KCNE3 channel complexes provide the basolateral K+ recycling in colonic crypt 
cells required to maintain the electrochemical driving forces behind lumenal Cl- secretion 
through CFTR at the apical membrane160.  This lead and the other studies cited in Chapter 
I establish a precedent for the importance of KV channels and KCNE modulatory subunits 
in the physiology of non-excitable tissues.  Because our data demonstrate that KCNE4 is 
expressed in a number of non-excitable tissues, any effort toward determining the native 
function of KCNE4 would be incomplete without considering potential roles in these 
systems. 
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On the other hand, KV channels are primarily studied for their contributions to the 
physiology of excitable cells, such as myocytes or neurons.  The electrical excitability of 
these cells stems directly from the capacity of their plasma membranes to respond to 
changes in voltage and to propagate an electrical signal; voltage-gated ion channels 
provide both of these functions.  Thus, in addition to considering potential roles for 
KCNE4 in non-excitable tissues as described above, it is critical to investigate its possible 
contributions to the physiology of excitable tissues. 
In vitro observations of the functional properties of KCNE4 and studies of its 
expression in human heart provide us with strong, specific leads in cardiac physiology.  
In heterologous expression systems, KCNE4 dramatically inhibits IKs70, a critical 
repolarizing current in the human cardiac action potential (Figure 5, Chapter I).  Further, 
expression of KCNE4 is robust in all regions of adult heart as well as in fetal heart70 
(Figure 9, Chapter I).   These findings as well as the physiologic functions in cardiac 
physiology already established for other members of the KCNE family lead us to believe 
that KCNE4 may be an endogenous regulator of IKs and contribute to fine-tuning of the 
cardiac action potential, with implications for heart rhythm and contractility. 
Because a primary focus of our lab is on the function of KCNE subunits in the 
context of cardiac electrophysiology and because of the compelling preliminary data 
identifying KCNE4 as a potential modulator of IKs, our initial effort in characterizing the 
function of KCNE4 has been directed to its potential role in cardiac physiology.  Our 
studies have been motivated by the hypothesis that KCNE4 is an endogenous negative 
regulator of IKs and/or other repolarizing K+ currents in the human cardiac action 
potential.  In this role, KCNE4 could serve to reduce repolarizing currents in cardiac 
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myocytes, thereby lengthening the QT interval, which may in turn have effects on 
excitation-contraction coupling and contractility. 
 
Kcne4-null mouse model 
Our primary approach to studying the function of KCNE4 in cardiac physiology 
was to characterize the cardiac phenotype of a Kcne4-null mouse.  As a model organism, 
the mouse offers many appealing traits: it is a mammal, has a short breeding cycle, is 
relatively easy to manipulate in many experimental systems, has a fully sequenced 
genome of approximately the same size as the human genome, and has been the target of 
many advanced gene transfer technologies.   
For the specific needs of this project, the mouse also presents considerable 
limitations.  Most critically, the cardiac electrophysiology of a mouse does not closely 
resemble human cardiac electrophysiology.  As shown in Figure 27, the mouse and 
human ventricular action potentials have distinct morphological differences owing to 
unique sets of underlying currents.  Of particular relevance, the currents responsible for 
repolarization (which we hypothesize may be critical targets of KCNE4 modulation) are 
not conserved between the two species.  In humans, the delayed rectifier potassium 
currents IKs and IKr contribute to an elongated repolarization phase characterized by its 
plateau.  By contrast, adult mouse ventricular cells express a different cohort of 
potassium channels with distinct time- and voltage-dependent properties.  These channels 
give rise to unique delayed rectifier currents (IK,slow1,  IK,slow2, and ISS) which contribute to 
a much abbreviated repolarization phase in the mouse compared to human161. 
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Figure 27. Human versus mouse ventricular cardiac action potentials.
Potassium currents contributing to repolarization differ markedly between the 
two species (red box).  In humans, Ito accounts for transient repolarization
(phase 1) followed by a plateau (phase 2) attributable to K+ efflux via IKs and IKr
balanced against Ca2+ influx via ICa,L.  As Ca2+ channels inactivate and K+
currents predominate, the cell rapidly repolarizes (phase 3) back to the resting 
potential.  By contrast, mouse ventricular cells do not prominently express IKs or 
IKr, but their unique repolarizing K+ currents IK,slow1, IK,slow2, and ISS drive rapid 
repolarization with no plateau phase.  Adapted from Nerbonne JM Trends 
Cardiovasc Med 14, 83-93 (2004).
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Despite these limitations, phenotypic characterization of mouse models following 
genetic manipulation of various K+ channels has provided much insight into molecular 
mechanisms underlying normal and pathological cardiac physiology94,162-171.  Thus we 
decided that a Kcne4-null mouse line could ultimately provide us the best opportunity to 
observe the effects of knocking out Kcne4 on cardiac electrophysiology in vivo.  In the 
studies described here, we acknowledge that our findings must be interpreted in the 
specific context of mouse physiology and our ability to generalize to human physiology 
is limited.  With these considerations, we hypothesized that if Kcne4 is an important 
negative regulator of repolarizing currents in the mouse cardiac action potential, the 
phenotype of Kcne4-null animals might include a shortened QT interval, possible 
enhanced susceptibility to or protection against cardiac arrhythmias, and possible 
contractile defects. 
 
Methods 
 
Breeding and marker-assisted selection to establish isogenic lines of Kcne4-/- mice 
 
Kcne4 knockout 
We obtained four Kcne4+/- founder mice from Lexicon Pharmaceuticals Inc., which 
were generated by homologous recombination in embryonic stem cells of the129/SvEv 
mouse strain, with a lacZ-containing Neo cassette replacing the entire coding region of 
Kcne4.  Recombinant cells were injected into early-stage host embryos of the C57BL/6 
albino strain and implanted into the uterus of a female C57BL/6 mouse.  Pups were bred 
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with selection for animals with the transgene in the germ cell line, and we received 
Kcne4+/- animals on a hybrid C57BL/6-129/SvEv background strain.   
 
Speed Congenics 
Because the C57BL/6 and 129/SvEv strains exhibit significant differences in 
cardiac physiology172 (Table 7) which could confound phenotypic findings, our first 
priority was to separately enrich each background strain and move our transgene to two 
isogenic lines.  To do this efficiently, we implemented a marker-assisted selection 
protocol while performing a series of backcrosses with pure C57BL/6 or 129S6/SvEv 
female mice to enrich that strain.  At each generation, the genomes of male Kcne4+/- pups 
were screened using 70 microsatellite markers that span the genome and can discriminate 
between the two strains, to deduce the percentage of C57BL/6 versus 129S6/SvEv 
background in each.  The most enriched male Kcne4+/- mouse was selected as the founder 
for the next generation, and so on.  This process allowed us to generate congenic litters of 
Kcne4+/+, Kcne4+/-, and Kcne4-/- mice within 4-5 generations.  Once congeneity was 
attained, we used Vanderbilt’s Transgenic / Embryonic Stem Cell Shared Resource Core 
to cryopreserve 632 Kcne4-/- embryos on the C57BL/6 background.  Of these, 45 
embryos (from two separate vials) were thawed to test viability, which yielded six live 
pups whose genotypes were confirmed as Kcne4-/-.  The Core continues to store the 
remaining 587 frozen embryos in 24 vials, for future repopulation of the mouse colony if 
necessary. 
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129/S6 C57BL/6 129/S6 C57BL/6
(n = 10) (n = 10) (n = 10) (n = 10)
Heart Rate (bpm)   571 ± 13 692 ± 5 <0.001 689 ± 12 741 ± 2*** <0.001
HR var (bpm) 15 ± 4 12 ± 3 0.850 20 ± 4 15 ± 3 0.331
PR (ms) 31.9 ± 1.3 26.0 ± 0.8 0.001 28.3 ± 0.6 24.4 ± 0.7 <0.001
QRS (ms) 9.6 ± 0.3 8.1 ± 0.2 <0.001 8.5 ± 0.1 7.5 ± 0.2 <0.001
QT (ms) 70.2 ± 1.8 55.4 ± 0.8 <0.001 54.7 ± 2.0 53.8 ± 0.6 0.672
QTc (ms) 66.7 ± 1.9 59.0 ± 0.8 0.002 58.4 ± 1.6 58.7 ± 0.3 0.856
Table 7. Electrocardiographic parameters in male and female 129/Sv and 
C57BL/6 conscious mice. Values are mean ± SEM.  HR var, heart rate 
variability; p, p-value following student t-test comparing strains. Adapted from 
Chu V et al., BMC Physiol. 2001; 1:6.
Males Females
p p
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Genotyping 
We employed a simple PCR assay that discriminates wild-type from transgenic 
alleles, using genomic DNA isolated from ear punches collected when pups were 3 weeks 
old.  Importantly, during this breeding process we observed that crosses exhibited a 
Mendelian ratio of Kcne4+/+, Kcne4+/-, and Kcne4-/- animals and all three genotypes are 
viable. 
 
Consequences of Kcne4 knockout on cardiac physiology at the whole-animal level 
 
Electrocardiography 
Adult mice were examined under isoflurane anesthesia for cardiac 
electrophysiological and arrhythmia phenotypes using high-resolution surface 
electrocardiography (ECG) recording. Anesthesia was induced with 3% inhaled 
isoflurane and maintained at 1.5-2%.  Following induction of anesthesia, an electrode 
was placed subcutaneously in each limb.  Four-lead ECGs were recorded and digitized at 
2 kHz using a data-acquisition board and custom-built software available in the 
laboratory of our collaborator, Dr. Bjorn Knollman.  ECGs were recorded continuously 
for at least five minutes, then electrodes were removed, isoflurane was withdrawn, and 
mice were allowed to recover under a warm lamp.  Comparisons of resting heart rate, PR, 
QT, and QRS duration were made from signal-averaged recordings among Kcne4+/+, 
Kcne4+/-, and Kcne4-/- littermates.  Rate-corrected QT interval, denoted QTc, was 
calculated using the Mitchell equation for mice QTc = QT/sqrt(RR/100).  Data were 
examined for evidence of conduction disturbances (eg. prolonged PR, increased QRS 
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duration) and abnormal rhythm, specifically for evidence of atrial and ventricular 
arrhythmias.  All measurements were performed off-line and blinded to genotype.  
Statistical significance for differences in the above parameters among groups was 
assessed using ANOVA followed by an appropriate post-test.  Separate analyses were 
performed for male and female animals. 
 
Echocardiography 
We evaluated myocardial contractile function in conscious Kcne4+/+, Kcne4+/-, and 
Kcne4-/- littermates using transthoracic echocardiography.  These studies were performed 
by an established core laboratory in the Division of Cardiovascular Medicine, which is 
equipped with a 15-MHz high-frequency transducer.  Measurements of left ventricular 
(LV) end-diastolic and end-systolic diameter, LV fractional shortening, and estimated LV 
ejection fraction were obtained from 2D guided M-mode images acquired at 100 frames 
per second.  Images were read off-line using short-axis and parasternal long-axis views 
by two independent investigators blinded to genotype.  Statistical significance for 
differences in the above parameters among groups was assessed using ANOVA with an 
appropriate post-test.  All studies were performed at two different ages (8 and 30 weeks) 
to investigate the age-dependence of the phenotype.  Separate analysis was performed for 
male and female mice. 
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Consequences of Kcne4 knockout on cardiac physiology at the cellular level 
 
Isolation of adult cardiac myocytes 
Isolation of adult mouse ventricular myocytes was performed following heparin 
injection (0.1 mL 5000 USP U/mL) under isoflurane anesthesia with rapid excision of the 
heart. The aorta was cannulated and the heart perfused in retro-aortic fashion with 
Modified Tyrode solution (mM: NaCl 130, NaH2PO4 1.2, glucose 10.0, KCl 5.4, MgCl2 
1.2, pH 7.2) for 3 min at 33.8-34.0 oC measured at the apex of the heart.  Type II 
collagenase (Worthington) at 0.5 mg/mL and type XIV protease at 0.05 mg/mL were 
added to the perfusate and the myocardium was perfused for 4-6 minutes, until fluid 
resistance in the tubing dropped by 50 % and the tissue began to turn pale in color.  The 
heart was then removed from the cannula, and the atria and ventricles were separated.  
Myocytes were dispersed by gentle agitation through a Pasteur pipette in a solution 
consisting of Modified Tyrode plus 1 mg/mL BSA, 1.0 mM MgCl2, 0.5 mM EDTA, and 
0.2 mM CaCl2 (pH 7.2).  Cells were washed twice in this solution (pelleting by gravity) 
then plated on coverslips for acute electrophysiological recordings. 
 
Electrophysiology 
All recordings were performed using the ruptured-patch technique at room 
temperature.  Recordings and subsequent analyses were performed blinded to the 
genotype of the cells. Statistical comparisons were made between groups from Kcne4+/+, 
Kcne4+/-, and Kcne4-/- littermates by one-way ANOVA with an appropriate post-test.  
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Current-clamp recordings -- Recordings were performed in normal Tyrode solution 
without blockers.  Action potentials were elicited with 2 ms square wave pulses (1-2 nA, 
or approximately 1.25 times threshold) at 1 or 0.3 Hz stimulation frequency.  Cells were 
paced at 1 Hz for 4 minutes, and sweeps 181-183 were averaged for analysis.  Action 
potential duration at 50 % (APD50) and 90 % (APD90) repolarization were determined as 
well as resting membrane potential and overshoot (peak membrane potential). 
Voltage-clamp recordings -- Examination of adult ventricular myocytes allowed for 
analysis of Ito, IK1 and Isus (comprised of IKslow,1 and IKslow,2).  Recordings were performed 
under conditions that suppress activation of Na+ and Ca2+ channels.  We recorded 
currents evoked by 4.5 s voltage pulses ranging from –40 to +40 mV (holding potential –
80 mV) in 10 mV increments. Distinct potassium currents were differentiated on the basis 
of their time dependence.  Current density normalized to cell capacitance was deduced 
for the individual currents. 
 
Results 
 
Consequences of Kcne4 knockout on general animal health 
We observed that Kcne4-/- mice of both background strains appear healthy, grow at 
the same rate as their Kcne4+/+ littermates, and can live in the research facility to at least 
18 months of age.   
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We acquired multi-system phenotyping data from Lexicon Pharmaceuticals, who 
generated the transgenic mouse line.  Among pertinent findings from their studies of F2 
mice on a hybrid C57BL/6-129/SvEv background are the following: 
 
 Kcne4-/- mice have significantly reduced conscious heart rate compared to 
Kcne4+/+ littermates (age 15 weeks): 558.6 ± 21.0 (n = 32) versus 635.2 ± 31.6 
bpm (n = 12); p = 0.05 for comparison of genotypes after allowing for effects of 
sex (two-way ANOVA) 
 No difference in mean systolic blood pressure (age 15 weeks) following 
measurements ten times daily by tail cuff for four days 
 Kcne4-/- mice have significantly reduced body temperature (measured rectally) 
compared to Kcne4+/+ littermates (age 12 weeks): 36.1 ± 0.24 (n = 8) versus 37.2 
± 0.34 °C (n = 4); p = 0.04 for comparison of genotypes after allowing for effects 
of sex (two-way ANOVA) 
 Kcne4-/- have significantly elevated blood phosphorous levels compared to 
Kcne4+/+ littermates (age 16 weeks): 6.1 ± 0.2 (n = 8) versus 4.8 ± 0.2 mg/dL (n = 
4); p = 0.001 for comparison of genotypes after allowing for effects of sex (two-
way ANOVA) 
 Kcne4-/- mice have significantly elevated blood calcium levels compared to 
Kcne4+/+ littermates (age 16 weeks): 9.6 ± 0.09 (n = 8) versus 9.3 ± 0.1 mg/dL (n 
= 4); p = 0.05 for comparison of genotypes after allowing for effects of sex (two-
way ANOVA)  
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 Kcne4-/- mice have a trend toward reduced blood glucose compared to Kcne4+/+ 
littermates (age 16 weeks): 80.1 ± 5.5 (n = 8) versus 100.8 ± 7.7 mg/dL (n = 4); p 
= 0.07 for comparison of genotypes after allowing for effects of sex (two-way 
ANOVA) 
 Kcne4-/- mice have a trend toward elevated blood cholesterol levels compared to 
Kcne4+/+ littermates (age 16 weeks): 122.3 ± 7.9 (n = 8) versus 95.0 ± 11.2 mg/dL 
(n = 4); p = 0.08 for comparison of genotypes after allowing for effects of sex 
(two-way ANOVA) 
 No difference in blood levels of albumin, alkaline phosphatase, alanine 
aminotransferase, blood urea nitrogen, creatinine, triglycerides, or uric acid (age 
16 weeks) 
 No difference in glucose tolerance nor blood insulin levels (age 15 weeks) 
 No abnormalities upon urinalysis assessing: leukocytes, nitrites, urobilinogen, 
protein, pH, blood, specific gravity, ketones, bilirubin, glucose (age 15 weeks) 
 No difference in body length at age 16 weeks, nor weight measured at 2-week 
intervals from age 2 weeks through 14 weeks 
 No difference in acute phase response (TNF, MCP-1, or IL-6 blood levels) 
following sublethal intraperitoneal LPS injection (age 18 weeks) 
 No difference in peripheral blood mononuclear cell profile assessing counts of: 
CD4+ cells, CD8+ cells, NK cells, B cells, monocytes (age 16 weeks) 
 No difference in hematology profile assessing: red cell count, white blood cell 
count, lymphocytes, neutrophils, eosinophils, basophils, monocytes, hemoglobin, 
hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean 
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corpuscular hemoglobin concentration, red cell distribution weidth, platelet count, 
mean platelet volume (age 16 weeks) 
 No difference in ability to produce IgG1 or IgG2 antibodies following antigen 
challenge (age 24 weeks) 
 No abnormalities observed by CT scan in 1 male Kcne4-/- mouse nor 1 female 
Kcne4-/- mouse, sedated with 1.25% 2,2,2,-tribromoethanol (20 ml/kg body 
weight), each age 30 weeks.  From report: “No abnormalities seen in gross skeleton, 
thorax, and abdomen. Liver, kidneys, and spleen appear normal in size, shape and 
position. The rate of excretion of contrast media by the kidneys is within normal limits, 
reflecting normal function.” 
 No differences in bone mineral density, percentage body fat, or lean body mass 
(age 15 weeks) 
 No observed deficits in gross neurological function as measured by a functional 
observation battery of tests from the Irwin neurological screen (age 12 weeks) 
 No observed deficits in nociception by hotplate test (latency to limb withdrawal 
on hotplate), age 12 weeks 
 No observed deficits or enhancements in motor strength by inverted screen (age 
12 weeks) 
 No difference in proliferative capacity of skin fibroblasts grown in culture 
following biopsy (age 20 weeks) 
 Pertinent findings from histological post-mortem studies in Kcne4-/- mice include: 
multifocal minimal protein casts and minimal focal regeneration of renal tubule 
(one of two mice); mild (2+) multifocal endometrial hyperplasia (one of one 
female mice); moderate (3+) chronic diffuse inflammation of pancreatic duct (one 
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of two mice); mild (2+) focal spermatocoele (one of one male mice); mild (2+) 
splenic hyperplasia (one of two mice) 
 
Consequences of Kcne4 knockout on cardiac physiology at the whole-animal level  
 
Shortened QT interval 
We recorded electrocardiograms in adult mice under isoflurane anesthesia in both 
strains, and in the C57BL/6 strain at two different ages (8-11 weeks and 30 weeks).  
While no difference in spontaneous arrhythmia susceptibility was noted among genotypes 
for any of the experimental groups, some changes in a number of ECG parameters were 
detected.  As shown in Figure 28 and Table 8, Kcne4-/- mice in all three experimental 
groups exhibited a trend toward shorter QT and QTc intervals versus Kcne4+/+ 
littermates, and in two of the experimental groups (C57BL/6 age 30 weeks and 
129S6/SvEv age 8 weeks) the difference in QTc was statistically significant.  Further, in 
the 129S6/SvEv strain, all other ECG parameters (RR, PR, QRS, QT) were significantly 
shortened in Kcne4-/- versus Kcne4+/+ mice. 
 
Left ventricular dilation and reduced fractional shortening 
Echocardiography performed on conscious adult Kcne4+/+, Kcne4+/-, and Kcne4-/- 
mice of each strain (and at two ages in the C57BL/6 strain, 8 weeks and 30 weeks) 
allowed us to assess whether Kcne4 knockout has any consequences for cardiac chamber 
dimensions or contractility.  As shown in Figures 29 and Table 9, C57BL/6 Kcne4-/- mice 
at age 8 weeks exhibit a significantly dilated left ventricular internal diameter during both 
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Figure 29. Echocardiography results from conscious C57BL/6, 8-week-
old mice. A, Representative dynamic M-mode images from wild-type and 
Kcne4-null mice.  B, Cardiac dimensions and working parameters calculated 
from M-mode recordings. n = 6 male + 6 female mice per group; *, p < 0.05; 
**, p < 0.01; ***, p < 0.001 for Tukey pairwise comparison to wild-type 
following two-way ANOVA comparing genotypes after allowing for effects of 
sex. LVID, left ventricular internal diameter; FS, fractional shortening; EF, 
ejection fraction; HR, heart rate.
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diastole and systole, as well as reduced fractional shortening and ejection fraction 
compared to Kcne4+/+ littermates.  A similar trend toward reduced fractional shortening 
and ejection fraction was observed for C57BL/6 Kcne4-/- mice at age 30 weeks (Figure 
30), though the differences were not statistically significant.  No differences in left 
ventricular internal diameter nor fractional shortening or ejection fraction were observed 
in 129S6/SvEv mice (Figure 31), and no difference in heart rate was observed in any of 
the experimental groups.  Importantly, the echocardiography studies also allowed us to 
monitor for arrhythmias in conscious mice, and none were detected in any of the 
experimental groups. 
 
Consequences of Kcne4 knockout on cardiac physiology at the cellular level 
 
Shortened action potential duration 
We performed preliminary current-clamp experiments on ventricular myocytes 
isolated from adult C7BL/6 and 129/S6 Kcne4+/+ and Kcne4-/- mice, including two age 
groups for the C57BL/6 strain (6-7 weeks and 13-15 weeks).  Figure 32 and Table 10 
illustrate our findings for action potential duration, resting membrane potential, and peak 
membrane potential for each experimental group.  A significant shortening of the action 
potential was observed for Kcne4-/- mice in the C57BL/6 age 13-15 week group, but not 
in the others.  
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Figure 30. Echocardiography results from conscious C57BL/6, 30-week-
old mice. A, Representative dynamic M-mode images from wild-type and 
Kcne4-null mice.  B, Cardiac dimensions and working parameters calculated 
from M-mode recordings. Kcne4+/+ and Kcne4+/-, n = 6 male + 6 female mice 
per group; Kcne4-/-, n = 5 male + 4 female mice. LVID, left ventricular internal 
diameter; FS, fractional shortening; EF, ejection fraction; HR, heart rate.
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Figure 31. Echocardiography results from conscious 129S6/SvEv, 8-
week-old mice. A, Representative dynamic M-mode images from wild-type 
and Kcne4-null mice.  B, Cardiac dimensions and working parameters 
calculated from M-mode recordings. n = 6 male + 6 female mice per group. 
LVID, left ventricular internal diameter; FS, fractional shortening; EF, ejection 
fraction; HR, heart rate.
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 +/+  -/- t-test  +/+  -/- t-test  +/+  -/- t-test
n = 12 n = 15 n = 9 n = 11 n = 23 n = 18
(2 mice) (2 mice) (2 mice) (3 mice) (3 mice) (3 mice)
APD50 (ms) 11.0 ± 0.62 14.1 ± 1.21 0.064 13.1 ± 1.11 10.5 ± 1.12 0.122 8.14 ± 0.38 8.23 ± 0.46 0.885
APD90 (ms) 36.5 ± 3.39 44.2 ± 3.82 0.152 45.7 ± 4.65 31.6 ± 4.14 0.035 19.2 ± 1.26 21.0 ± 1.69 0.380
Resting Vm (mV)  -61.7  ± 1.01  -62.4 ± 0.57 0.485  -59.7 ± 1.46  -61.6 ± 0.68 0.231  -63.0 ± 0.64  -60.9 ± 0.44 0.013
Peak Vm (mV) 49.7 ± 1.92 56.4 ± 1.79 0.016 48.1 ± 3.69 49.4 ± 3.04 0.788 47.9 ± 1.37 47.7 ± 2.07 0.926
Table 10. Mean ± SEM for action potential parameters in ventricular 
myocytes from adult mice, plus p-values for student-t test comparing 
genotypes.
C57BL/6, 6-7 weeks C57BL/6, 13-15 weeks 129/S6, 8-10 weeks
p p p
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No change in Ito, Isus, or IK1 
We performed preliminary voltage-clamp experiments on ventricular myocytes 
isolated from adult C57BL/6 Kcne4+/+ and Kcne4-/- mice.   Figure 33 illustrates our 
findings for Ito, Isus, and IK1.  No significant differences in current density were observed 
at any test potential for any of the potassium currents.   
 
Discussion 
An important basic observation from these studies is that Kcne4-null mice can live 
a normal lifespan with no major gross deficits.  However, the collection of findings from 
focused phenotyping studies point to possible physiologic functions for Kcne4 in the 
mouse and help us assess our hypothesis that Kcne4 may be an endogenous negative 
regulator of repolarizing currents in the cardiac action potential.   
The broad set of data we acquired from Lexicon is useful as a preliminary screen of 
a number of physiological systems, but these data must be interpreted in the context of a 
major limitation: that the studies were performed on F2 mice on a hybrid background.  
Given that significant physiological differences exist among the C57BL/6 and 
129S6/SvEv strains, variability in genetic background among mice in the F2 generation 
makes it difficult to attribute any differences observed among groups of mice specifically 
to their Kcne4 genotype.  With this limitation in mind, specific findings that are worth 
follow-up studies in congenic strains include decreased body temperature and resting 
heart rate, elevated blood phosphorous and calcium levels, and reduced blood glucose 
levels in Kcne4-/- mice.  Collectively, these findings point toward potential metabolic 
disorders, which could involve impaired thyroid, parathyroid, or kidney function. 
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 In considering specifically the effect of Kcne4 knockout on cardiac 
electrophysiology, the preliminary studies reported here provide some evidence to 
support our hypothesis that Kcne4 is an endogenous negative regulator of repolarizing 
currents in the mouse cardiac action potential.  The observation of a shortened QTc (rate-
corrected QT) interval by ECG in Kcne4-/- mice of both strains under isoflurane 
anesthesia (Figure 28) is consistent with that hypothesis: shortened repolarization time 
could be attributable to the absence of an inhibitor of repolarizing currents.   
The finding of a shortened QTc interval in Kcne4-/- mice by ECG is further 
supported by the observation of a shortened APD90 in isolated ventricular myocytes from 
C57BL/6 Kcne4-/- mice at age 13-15 weeks (Figure 32).  It is difficult to explain why 
shortening of the action potential was not also observed in 129S6/SvEv Kcne4-/- mice 
(given the observation of a shortened QTc interval in these mice), though a number of 
experimental limitations may play a role.  The data in Figure 32 reflect recordings made 
from cells that were isolated from just two or three mice per group.  A small sample size 
may magnify any effects attributable to variability in cell quality and/or cell origin (eg. 
epicardium versus endocardium), which cannot be ruled out given the challenging nature 
of the myocyte isolation procedure. 
These experimental limitations (small n, variable cell populations, imperfect 
recording techniques) may also explain why we did not observe any differences in K+ 
currents recorded in ventricular myocytes from adult C57BL/6 Kcne4+/+ versus Kcne4-/- 
mice (Figure 33), despite having observed a shortened action potential in Kcne4-/- mice.  
Alternatively, it is possible that Kcne4 knockout has no effect on ventricular K+ currents, 
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and the findings of shortened repolarization time by action potential and ECG recordings 
were merely artifacts.  Further studies are needed to resolve these inconsistencies and 
secure a complete set of reliable data. 
 
There were a number of findings from our cardiac phenotyping studies that we did 
not anticipate.  One example is the ECG finding of a shortened RR interval in Kcne4-/- 
mice in the 129S6/SvEv strain, with concurrent shortening of the PR and QRS intervals.  
These findings may indicate that pacemaker cells are firing at a higher frequency in 
Kcne4-/- mice, or that conduction from the sinus node through the AV node is occurring 
at a faster rate.  It should be noted that calculating the rate-corrected QTc interval allows 
for assessing the relative length of the QT interval compared to the overall RR length.  
Whereas the finding of shortened PR and QRS intervals can be attributed to shortening of 
the entire cardiac electrical cycle, the finding of a shortened QTc implies that other 
factors are at play to specifically shorten ventricular repolarization. 
The finding of a shortened RR interval in 129S6/SvEv Kcne4-/- mice is inconsistent 
with the report from Lexicon that Kcne4-/- mice have a lower resting heart rate, and also 
with our own findings from echocardiography studies (Figures 29, 30, 31) that there are 
no differences in resting heart rate among Kcne4 genotypes in either strain.  One 
interpretation that can reconcile these three conflicting findings is as follows: the results 
from the echocardiograms may be considered the ‘true’ or most meaningful data 
reflecting resting heart rate, since these experiments were performed in conscious mice 
from congenic backgrounds, whereas the Lexicon studies used mice from hybrid 
backgrounds, and our ECG finding of increased heart rate in Kcne4-/- mice may reflect a 
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difference in response to isoflurane anesthesia rather than resting heart rate.  
Alternatively, the dramatic inconsistency among these three studies of heart rate may 
reflect major limitations inherent in one or all of our experimental approaches. 
We also observed unexpectedly that Kcne4 knockout mice exhibit impaired 
myocardial contractility by 8 weeks of age.  Cardiac chamber dimensions of conscious 
mice measured via echocardiography suggest that C57BL/6 Kcne4+/- and Kcne4-/- mice 
have increased LV internal diameter during diastole and systole (LVIDD, LVIDS, 
respectively) and decreased LV fractional shortening (FS) and ejection fraction (EF) 
compared to wild-type (Kcne4+/+) littermates (Figures 29, 30, 31). While we did not 
anticipate this finding, we hypothesize that impaired myocardial contractility could be an 
additional functional consequence of enhanced repolarizing currents (such as Ito) in 
Kcne4-/- mice caused by dampened intracellular calcium transients and impaired 
excitation-contraction coupling, consistent with the relationship between Ito and Ca2+ 
signaling in rodents described by others156,173-176.  Further discussion of this hypothesis 
and a description of future studies that could be performed to test it directly can be found 
in Chapter V. 
 
Overall, we cannot draw many final conclusions but are presented with a number of 
interesting leads from the work reported here following initial characterization of the 
Kcne4 knockout mouse.  Important future directions not already mentioned include 
studying the electrophysiology of neonatal cardiac myocytes, which, compared to adult 
cells, express a different cohort of K+ channels and rely on a unique set of currents for 
repolarization (including IKs).  It is possible that Kcne4 is an important modulator of 
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neonatal K+ currents and that electrophysiological findings in Kcne4-/- mice may be more 
pronounced in this setting.  Other important considerations when interpreting any 
phenotyping data from the Kcne4-/- mouse include the possibility that the expression of 
other Kcne genes may change in compensation for the lack of Kcne4, as well as the 
important limitations described previously related to the imperfect parallels between 
human and mouse cardiac electrophysiology. 
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CHAPTER V 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Summary 
KCNE1-KCNE5 comprise a family of KV channel modulating proteins that evoke 
diverse functional effects, are expressed by a broad range of human tissues, and in some 
cases are known to contribute to cellular functions that are required for normal 
physiology. Though KCNE4 demonstrates a remarkable ability to extinguish distinct K+ 
currents in heterologous expression systems, we lack a clear understanding of both its 
mechanism for doing so and its physiologic significance. This project sought evidence 
that could improve our understanding of the physiological functions of KCNE4, through 
identification of its protein interacting partners and an assessment of the consequences of 
Kcne4 knockout in mouse cardiac physiology. 
 
A membrane-based yeast two-hybrid (MbYTH) screen for protein interacting 
partners of KCNE4 using a cDNA library from adult human brain yielded 98 clones that 
were positive for an interaction with KCNE4 based on both a primary growth assay and a 
secondary lacZ expression assay. Among those 98 clones we pursued follow-up analysis 
for 20, and ultimately identified their parent genes. These putative KCNE4 interacting 
partners include five membrane-associated proteins, eleven cytoplasmic proteins, three 
nuclear proteins, and one protein of unknown localization (Table 4). The set of 
interacting proteins did not include any KV channels as we had hoped, in order to identify 
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novel channel targets of modulation by KCNE4. However, identification of non-KV 
channel protein interacting partners did provide useful leads toward understanding other 
aspects of the function of KCNE4 – for example, its trafficking, its regulation, and 
potential cellular functions beyond direct modulation of channel activity. 
 
The MbYTH ‘hit’ with the most obvious potential for intersection with KCNE4 was 
calmodulin (CaM), which is a known modulator of voltage-gated ion channels including 
KCNQ1. Interactions between accessory subunits (e.g., KCNE) and other regulatory 
proteins associated with macromolecular channel complexes such as IKs are emerging as 
another layer of complexity in regulating channel function. We demonstrated a Ca2+-
dependent biochemical interaction between KCNE4 and CaM (Figure 21) and that 
KCNQ1 functional modulation by KCNE4 is impaired both upon mutation of a candidate 
CaM-interaction site (L[69-72]A) in the juxtamembrane region of KCNE4 (Figure 24) 
and by acutely chelating [Ca2+]i to displace CaM from KCNE4 (Figure 26). These 
findings suggest a connection between the mechanism of KCNQ1 inhibition by KCNE4 
and the activating effect of CaM on the channel. Whereas we had previously assumed 
that the inhibition of KCNQ1 by KCNE4 is caused by a direct effect of KCNE4 on the 
channel, the data in this study introduce the new possibility that KCNE4 inhibits KCNQ1 
by disrupting CaM-mediated activation. 
 
Analysis of a Kcne4-/- mouse constituted our other approach to uncovering the 
physiologic significance of KCNE4. We hypothesized that Kcne4 may be an endogenous 
negative regulator of repolarizing currents in the cardiac action potential, and that Kcne4-
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null mice might display a shortened QT interval, with possible implications for 
arrhythmia susceptibility or excitation-contraction coupling. Although the Kcne4-null 
mice did not display an increased susceptibility to arrhythmia versus their wild-type 
littermates, ECG analysis revealed that Kcne4-null mice of both the C5BL/6 and 
129S6/SvEv strains have a shortened QTc interval compared with wild-type mice under 
isoflurane anesthesia (Figure 28). Our hypothesis was also supported by the observation 
of a shortened APD90 in isolated ventricular myocytes from C57BL/6 Kcne4-null mice at 
age 13-15 weeks (Figure 32), though this finding was not consistent across both mouse 
strains. 
Unexpectedly, we also observed that C57BL/6 Kcne4-null mice have impaired 
myocardial contractility by eight weeks of age (Figure 29). Cardiac chamber dimensions 
of conscious mice measured by echocardiography suggest that C57BL/6 Kcne4+/- and 
Kcne4-/- mice have increased left ventricular (LV) internal diameter during diastole and 
systole and decreased LV fractional shortening (FS) and ejection fraction (EF) compared 
to wild-type littermates. 
 
Unanswered questions that remain or have been generated by this work include: 
What can we learn about KCNE4 in human cardiac electrophysiology from the Kcne4 
knockout mouse? What is the molecular etiology of left ventricular dilation and reduced 
fractional shortening in Kcne4 knockout mice? What are the non-cardiac phenotypes of 
the Kcne4 knockout mouse? How do KCNE4, KCNQ1, and CaM interact to yield the 
functional findings in Chapter III? What is the physiologic significance of the Ca2+- 
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sensitivity of KCNQ1 inhibition by KCNE4 and the KCNE4-CaM interaction? What is 
the functional significance of the other 19 KCNE4 MbYTH hits? 
 
Future Directions 
 
Biochemical and Functional Validation of KCNE4 interaction with MbYTH ‘hits’ 
The degree to which an apparent connection between KCNE4 and the other 19 
MbYTH hits exists varies considerably among the putative interaction partners. The 
appearance of several DNA-binding proteins among the ‘hits’ is particularly interesting 
in light of a previous study which described the ability of a C-terminal fragment of the 
voltage-gated calcium channel CaV1.2 to translocate to the nucleus and regulate 
expression of a number of genes through its interaction with other nuclear proteins130. A 
similar function is conceivable for KCNE4, especially because it has a long C terminus 
(unique among the KCNE proteins), the importance of which is not known. Because 
demonstration of an interaction with transcription factors has the potential to 
revolutionize our understanding of the function of KCNE4, studies are proposed here to 
pursue biochemical and functional validation of the interactions between KCNE4 and 
DNA-binding proteins SIRT2, GTF2H4, and CEBPZ. 
We can begin by validating the biochemical interaction between KCNE4 and each 
of the putative nuclear interaction partners by coimmunoprecipitation studies. The 
specificity of each interaction can be checked against the other KCNE proteins, which 
will also help elucidate which structural domains of KCNE4 are necessary for interaction 
with each nuclear protein. Subsequently, we can generate KCNE4 truncation constructs 
123
by incremental removal of N- and C-terminal sequences and assess their interaction with 
the nuclear protein to define a minimal KCNE4 peptide sequence that is required for its 
biochemical interaction with the nuclear protein. 
If interaction between KCNE4 and any of the nuclear proteins is confirmed, then 
we can assess whether a KCNE4 cleavage product (including the minimal KCNE4 
sequence identified above) is detectable in native cells. Several different approaches can 
be used to this end: we can probe nuclear extracts from native cells using an antibody 
against the appropriate portion of KCNE4 and look for full-length KCNE4 plus the 
cleavage product by Western blot; alternatively, we can study localization of KCNE4 in 
intact cells by immunofluorescence to determine if KCNE4 localizes to the nucleus. 
If nuclear localization of a KCNE4 cleavage product is observed, then we can seek 
to identify genes it might regulate. As an initial approach, we can use microarray analysis 
to compare gene expression in cells transfected with full-length KCNE4 versus a 
truncation mutant that demonstrates deficient interaction with the DNA binding protein, 
and also versus cells transfected with empty vector. Any gene that is found to be 
significantly up- or down-regulated in the presence of KCNE4 can be further validated as 
a target of transcriptional regulation by KCNE4 using quantitative RT-PCR analysis or a 
reporter assay using the firefly-luciferase gene fused to the promoter/enhancer region of 
the target gene to assess relative expression in the presence versus absence of KCNE4. 
Anticipated Results: If we can demonstrate a biochemical interaction between 
KCNE4 and any of the DNA-binding proteins that were identified in the MbYTH screen 
as putative interacting partners, then we will have an intriguing lead toward a new role 
for KCNE4 as a potential transcriptional regulator. We expect that an interaction between 
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KCNE4 and a nuclear protein could only take place if a cleavage event liberated a portion 
of KCNE4 to translocate from the membrane to the nucleus. Identification of up- or 
down-regulated genes following KCNE4 expression may provide direct evidence linking 
KCNE4 to new cellular functions, which may or may not be related to any of the 
phenotypes observed in the Kcne4-/- mouse.  
Experimental Limitations: Proteolytic cleavage of the KCNE4 C-terminus to allow 
translocation to the nucleus and transcriptional regulation may only occur under certain 
cellular conditions. It may thus be difficult to determine and apply the conditions (eg. 
stimulation by a specific agonist, or free [Ca2+] within a certain range) needed to detect 
an interaction between KCNE4 and the candidate nuclear proteins or to elicit changes in 
the expression profile of a target gene, and negative results will be difficult to interpret. 
 
Further characterization of KCNE4-CaM interaction 
 
1. What molecular mechanism links KCNQ1, CaM and KCNE4? 
Our demonstration of a Ca2+-dependent biochemical interaction between KCNE4 
and CaM, and that KCNQ1 functional modulation by KCNE4 is impaired both upon 
mutation of a candidate CaM-interaction site in the juxtamembrane region of KCNE4 and 
by acutely chelating [Ca2+]i to displace CaM from KCNE4, suggests a connection 
between the mechanism of KCNQ1 inhibition by KCNE4 and the activating effect of 
CaM on the channel. Clearly delineating any link between these findings as it pertains to 
the mechanism of KCNE4 inhibition of KCNQ1 is the most important next step for this 
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work. An enticing hypothesis that could tie these observations together is that KCNE4 
inhibits KCNQ1 by disrupting CaM-mediated KCNQ1 activation. 
Biochemical demonstration of disruption of the CaM-KCNQ1 interaction in the 
presence of KCNE4 would constitute strong evidence in support of our hypothesis, but 
this is difficult to achieve experimentally and there are likely to be multiple confounding 
interpretations of such experiments. For example, biochemical assays such as CaM-
agarose pull-down or co-immunoprecipitation require complete displacement of CaM 
from KCNQ1 in the presence of KCNE4 to yield an observable effect, whereas KCNE4 
may cause a conformational change that is sufficient to prevent transduction of the 
activating signal CaM provides to KCNQ1 without fully disrupting CaM and KCNQ1 
interactions. Further, we do not know the KCNQ1-KCNE4-CaM stoichiometry in 
functional channel complexes. The presence of KCNE4 may displace some but not all 
CaM molecules from a given KCNQ1 channel complex -- enough to affect channel 
function but perhaps leaving enough KCNQ1-CaM complexes intact to produce no 
observable change in a biochemical assay.  Finally, a given cell may express mixed 
populations of KCNQ1 channel complexes – some that include KCNE4 as well as some 
that do not, leaving the possibility that even when KCNE4 is coexpressed some KCNQ1-
CaM complexes will be intact, yielding a positive interaction by biochemical assay. 
Instead, a structural approach will probably be needed to address the question of 
whether the KCNQ1-CaM interaction is disrupted in the presence of KCNE4, and given 
the limitations described previously for solving structures composed of KCNQ1 and 
KCNE subunits, acquiring those data may depend on application of innovative methods 
for structural analysis. In the meantime, we can address the question indirectly by making 
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use of the KCNE1-KCNE4 chimeras we generated for a previous investigation into 
which domains of KCNE4 are required for its inhibitory effect on KCNQ148, and 
exploiting our observation that KCNE1 does not interact biochemically with CaM. By 
studying functional and biochemical properties of each of the chimeric proteins, we can 
assess whether the ability to inhibit KCNQ1 segregates with an ability to interact 
biochemically with CaM.  
Anticipated Findings: If our hypothesis is correct and the mechanism for KCNQ1 
inhibition by KCNE4 involves KCNE4 disruption of the CaM-mediated KCNQ1 
activation, then we expect to find that KCNQ1 inhibitory properties are conferred only to 
those KCNE1-KCNE4 chimeras that can interact biochemically with CaM. Ultimately, 
we can learn from structural studies how CaM mediates its activating effect on KCNQ1, 
and seek evidence that supports our hypothesis that in the presence of KCNE4 that effect 
is disrupted. 
 
2. What is the physiologic significance of the KCNE4-CaM interaction?  
The physiological implications of the interaction between KCNE4 and CaM may be 
significant, but are difficult to assign because of the primary lack of understanding of the 
physiological contributions of KCNE4. In heart, where KCNE4 could modulate 
repolarizing currents such as IKs, and where local free Ca2+ concentrations cycle 
dramatically, the Ca2+-CaM sensitivity described for KCNE4 may enable Ca2+-dependent 
regulation of repolarization time. Because repolarization time is critical for action 
potential duration as well as Ca2+ release and contractility, CaM-KCNE4 interactions 
might constitute part of a feedback loop for regulating intracellular Ca2+. 
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To investigate the physiologic significance of the KCNE4-CaM interaction, we can 
study guinea pig or rabbit myocytes expressing the CaM-insensitive KCNE4 mutant 
L[69-72]A. After applying overexpression techniques described below (biolistics or viral 
delivery of wild-type versus mutant KCNE4 cDNA), we can assess the effects of 
disrupting the interaction between KCNE4 and CaM on myocyte K+ currents, action 
potential duration and morphology, Ca2+ transients, and cell shortening. 
Anticipated Findings: If KCNE4 is an endogenous inhibitor of IKs in guinea pig or 
rabbit cardiac myocytes, then we expect that the CaM-insensitive KCNE4 mutant will 
exhibit impaired IKs inhibition, and we will record enhanced IKs and shortened action 
potentials in myocytes expressing L[69-72]A. Concurrently, we may observe altered Ca2+ 
transients and myocyte contractility due to effects of repolarization time on excitation-
contraction coupling. 
Experimental Limitations: Unless the L[69-72]A mutant exerts a dominant-negative 
effect, we may have to knock down endogenous Kcne4 in conjunction with expression of 
exogenous L[69-72]A in order to uncover its effects on native K+ currents. Lentiviral 
delivery of anti-Kcne4 shRNA sequences can be used to achieve this goal, as described 
below. Additionally, we may have to apply an adrenergic agonist or other factor that can 
upregulate CaM signaling in order to unmask any effects of the CaM-insensitive KCNE4 
mutant on native cardiac myocyte electrophysiology. 
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Further characterization of the Kcne4-knockout mouse 
 
1. What are the implications of shortened repolarization time in Kcne4-null mice 
for human cardiac electrophysiology? 
 
Given the differences between the human and mouse ventricular cardiac action 
potentials (most notably in repolarizing K+ currents, see Figure 27), it is important not to 
over-interpret findings in the Kcne4 knockout mouse when considering how KCNE4 
might contribute to human cardiac physiology. A valuable next step in testing how our 
mouse findings translate to more human-like cardiac electrophysiology is to assess the 
effects of KCNE4 silencing and overexpression in ventricular myocytes with a human-
like electrophysiological profile, for example those from guinea pig or rabbit. 
Guinea pig and rabbit ventricular myocytes are known to express similar 
repolarizing currents to those in humans177,178, and they can be cultured and genetically 
manipulated following isolation. We are currently optimizing protocols for several 
methods of gene silencing and overexpression in rabbit and guinea pig myocytes. 
Overexpression will be achieved either by biolistics or viral delivery of human KCNE4 
cDNA (plus a fluorescent marker to enable selection of cells expressing the exogenous 
subunit). Gene silencing will be achieved using lentiviral delivery of shRNAs targeting 
endogenous Kcne4; infected cells will also express a fluorescent marker and an antibiotic 
resistance gene for selection, and we will confirm Kcne4 knockdown with analysis of 
Kcne4 protein expression by Western blot, and/or of Kcne4 transcripts by quantitative 
real-time RT-PCR. 
Following KCNE4 overexpression or silencing of endogenous Kcne4, we will 
perform voltage-clamp and current-clamp experiments in order to record K+ currents and 
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action potentials, respectively, using methods described in Chapter IV for experiments on 
isolated mouse myocytes. By comparing K+ currents and action potential duration and 
morphology in cells overexpressing KCNE4 versus empty vector, or in cells following 
Kcne4 silencing with targeted shRNA sequences versus scrambled controls, we can 
directly assess the contributions of KCNE4 to the electrophysiology of ventricular 
myocytes in a cellular model with an electrophysiologic profile that closely resembles 
that of human cardiac myocytes.  
Anticipated Results: If KCNE4 is an endogenous inhibitor of repolarizing currents 
in these species (consistent with our hypothesis and with our findings in mice), we 
anticipate observing reduced K+ currents and increased action potential duration in 
KCNE4 overexpression studies, and enhanced K+ currents and reduced action potential 
duration in Kcne4 silencing studies. 
Experimental Limitations: As with any cells that have been cultured outside of their 
native environment, cardiac myocytes will be imperfect physiologic models by the time 
we record K+ currents and action potentials from them. Nonetheless, we expect these 
studies will provide valuable insight into the contributions of KCNE4 to cardiac 
electrophysiology. 
 
2. What is the etiology of impaired cardiac contractility in Kcne4-null mice? 
Our unexpected observation of left ventricular dilation and reduced fractional 
shortening in Kcne4-/- mice by 8 weeks of age warrants investigation into the connection 
between Kcne4 and myocardial contractility. Given our preliminary observations 
suggesting that Kcne4 is an endogenous negative regulator of cardiac repolarization, we 
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hypothesize that impaired myocardial contractility is a functional consequence of 
enhanced Ito in Kcne4-/- mice caused by dampened intracellular calcium transients and 
impaired excitation-contraction coupling, consistent with the relationship between Ito and 
Ca2+ signaling in rodents described by others156,173-176 and reviewed by Sah et al179.  
Ito is responsible for early phase repolarization during the cardiac action potential, 
and is closely linked to downstream excitation-contraction coupling.  The transient rise in 
intracellular free calcium [Ca2+]i that triggers cardiac myocyte contraction is generated 
primarily by Ca2+ influx from the sarcoplasmic reticulum (SR) through ryanodine-
sensitive Ca2+ release channels (RyR2).  In turn, RyR2 channels are gated by local 
increases in [Ca2+]i that occur with opening of sarcolemmal L-type Ca2+ channels (LTCC) 
in response to membrane depolarization179-182.  The tight regulation of LTCC by 
membrane voltage makes the amplitude, frequency, and time course of calcium transients 
(and by extension, myocyte contractility) susceptible to modulation by the action 
potential profile156,173,174,183.  The early repolarization phase of the cardiac action potential 
is particularly influential in regulating the open probability of LTCC and the efficiency of 
downstream excitation-contraction coupling (ECC)156,173,174,184.  Thus, factors that 
modulate the biophysical properties of Ito can regulate calcium transients and myocyte 
contractility179. 
Factors that decrease Ito and prolong early repolarization in rodents ultimately 
increase Ca2+ transients and potentiate contractile strength, as has been demonstrated in 
several settings: rat myocytes following administration of the Ito blocker 4-aminopyridine 
(4-AP)173, rat myocytes with decreased Ito following myocardial infarction174, and 
myocytes from transgenic mice overexpressing dominant-negative Ito subunits176.  This 
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effect is opposite that which is observed in larger mammals (including rabbits, dogs, and 
humans), in which Ito inhibition decreases Ca2+ transients and impairs ECC and myocyte 
contractility184.  This dichotomy is highlighted by work from the Backx laboratory179. 
There is considerable evidence suggesting that Ito is generated by channel 
complexes consisting of KV4.2 and/or KV4.3 pore-forming subunits, including extensive 
functional data from heterologously expressed candidate KV subunits185-187, observations 
of KV channel expression in native cardiac tissue188,189, results from mRNA knockdown 
and adenoviral gene transfer studies in native cardiac myocytes183,190-192, plus 
observations in transgenic animal models163,166,193,194.  However, Ito exhibits high 
variability in its biophysical properties among species and within cardiac regions of a 
given species91,92,194-197. 
Understanding of the regulation and molecular determinants of Ito is incomplete.  
Recent studies have examined whether the KCNE proteins may contribute to modulation 
of Ito, and electrophysiological data from CHO cells heterologously co-expressing KV4.3 
plus KChIP (a probable accessory subunit in the endogenous Ito channel complex) in 
addition to individual KCNE proteins indicates that each KCNE subunit is capable of 
modulating the biophysical properties of this reconstituted Ito-like current98. KCNE4 has 
been observed to modulate KV4.2-ChIP2 channels (specifically by slowing activation and 
shifting voltage-dependence of activation toward more positive potentials). KCNE4 was 
also found to co-localize with KV4.2 to transverse tubules of rat cardiac myocytes, and it 
was co-immunoprecipitated with KV4.2 and KChIP2 following heterologous expression 
in tsA201 cells97. Our preliminary mouse studies did not indicate that Ito is enhanced in 
cardiac myocytes from Kcne4-null mice, but a number of experimental limitations 
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(described in Chapter IV) could account for the negative results and further study is 
necessary.  
If we demonstrate that Ito is enhanced in Kcne4-null mice, we will pursue our 
hypothesis that Kcne4+/- and Kcne4-/- mice exhibit LV dilation and reduced FS and EF 
because of a functional effect: loss of Ito suppression by KCNE4, accentuated early phase 
repolarization and blunted intracellular calcium transients.  As a consequence, we predict 
that cardiac myocytes from Kcne4-/- mice will display blunted calcium transients and 
reduced cell shortening as compared to wild-type animals in response to electrical 
stimulation. Further, we predict that blocking Ito pharmacologically will restore normal 
contractility and correct aberrations in calcium signaling.  Our Kcne4 knockout mouse 
line enables us to directly test this hypothesis, using the following set of experiments. 
 
A. Further phenotypic characterization 
Because impaired contractility can arise from structural defects of the heart198 
including myocardial fibrosis, we first plan to perform post-mortem analysis of cardiac 
chamber morphology and histology to investigate this possibility. We can analyze major 
morphological features (including myocardium, valves, coronary arteries, and the great 
vessels) by dissection and gross examination.  Separately, we can study tissue sections 
stained with hematoxylin and eosin for histological analysis by standard light microscopy 
and Sirius red for quantification of fibrosis.  We will quantify right and left ventricle 
chamber size, and evaluate the extent of ventricular fibrosis. 
Additionally, to investigate whether there is age-dependence of impaired 
contractility, we can perform echocardiograms on conscious Kcne4+/+, Kcne4+/-, and 
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Kcne4-/- mice at age 30 weeks and compare these findings stratified by sex and genotype 
with our data obtained on 8 week old mice.  Further, we can assess whether Kcne4 
knockout mice exhibit physiological and pathological signs associated with heart failure, 
by measurement of systemic blood pressure at ages 8 and 30 weeks, and by gross and 
histologic analysis of pulmonary morphology to look for signs of edema. 
Anticipated Results: We predict that gross and histological analysis of cardiac 
morphology will demonstrate that the hearts of Kcne4+/- and Kcne4-/- mice are free of any 
structural defects (such as valvular disease, coronary artery disease, aortic stenosis, or 
fibrosis) that could account for the observed impaired myocardiac contractility. This 
prediction is consistent with our preliminary inspection of the animals over several 
generations that suggest that general health does not deteriorate with advancing age. 
Further, we predict that 30-week-old Kcne4+/- and Kcne4-/- mice will display a similar 
degree of LV dilation and FS impairment as 8-week-old mice.  It is also conceivable that 
as the mice age their hearts engage compensatory mechanisms to restore adequate 
contractile strength and cardiac output.  If this is the case, then we can elucidate those 
mechanisms through electrophysiological recordings and measurements of calcium 
transients in cardiac myocytes using approaches outlined below. Similarly, we do not 
anticipate that Kcne4+/- and Kcne4-/- mice will exhibit overt clinical signs of heart failure 
but we need to systematically examine the animals for the potential pathophysiological 
consequences of impaired myocardial contractility to document the full spectrum of the 
phenotype.  
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B. Assessment of Ca2+ signaling and myocyte shortening 
We hypothesize that Kcne4-/- mice have impaired contractility due to diminished 
amplitude of intracellular calcium transients as a consequence of enhanced Ito.  We can 
test this hypothesis by comparing calcium transients and cell shortening in ventricular 
cardiac myocytes from Kcne4+/+ and Kcne4-/- mice. We will perform these studies using 
dual-beam excitation fluorescence photometry and the IonOptix system for measuring 
calcium transients and cell shortening in cardiac myocytes. 
After isolating individual ventricular myocytes from excised hearts of 8-week-old 
Kcne4+/+ and Kcne4-/- mice we will load the cells with the fluorescent calcium ratiometric 
indicator fura-2 acetoxymethyl ester (fura-2) and begin field stimulation with 1Hz pacing.  
After 5 minutes of steady-state pacing, we will obtain 10-second records of calcium 
transients and myocyte shortening, using excitation wavelengths of 360 and 380nm to 
monitor the fluorescence signals of Ca2+-bound and Ca2+-free fura-2.  Subsequently, we 
will expose the myocytes to 10 mM caffeine and record caffeine-induced Ca2+ transients 
to estimate total SR content.  After subtracting background and cellular autofluorescence, 
[Ca2+] will be deduced from the fluorescence ratio (Fratio) at 360nm and 280nm 
excitation199.   
Ca2+ transients and ventricular myocyte shortening will be analyzed using 
specialized data analysis software, allowing us to compare the following parameters 
between Kcne4-/- and Kcne4+/+ cells: diastolic calcium Fratio, peak Fratio of Ca2+ transient, 
time-to-peak, time to 50% peak, time constant of Ca2+ transient decay, time to 90% 
relaxation, SR Ca2+ content, fractional SR Ca2+ release, diastolic myocyte segment 
length, % fractional shortening, time to peak cell shortening, time to 50% peak cell 
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shortening, time to 90% peak cell shortening. If we observe abnormal Ca2+ transients 
and/or impaired cell shortening in Kcne4-/- cells, then we can test whether 
pharmacological Ito blocking agents such as 4-AP and Heteropoda toxin-3 (HpTx-
3)194,200,201 can normalize these cellular phenomena.  
Anticipated Results: We predict that ventricular myocytes from Kcne4-/- mice will 
exhibit a lower peak Fratio corresponding to field-stimulated Ca2+ transients, indicating 
smaller rises in intracellular calcium concentration in these cells as compared with 
myocytes from Kcne4+/+ mice.  Further, we predict that cell shortening will be attenuated 
in Kcne4-/- myocytes.  Time-to-peak Fratio and cell shortening may also be reduced if 
accentuated early repolarization in Kcne4-/- cells promotes shorter open-times for SR and 
plasma membrane Ca2+ channels. We further anticipate that pharmacological Ito blockers 
will normalize these defects and this would provide evidence for a link between this 
repolarizing current and contractile force. 
Experimental limitations: The proposed experiments are based on our observation 
that Kcne4-null mice have shortened action potential duration and our prediction that 
Kcne4 knockout is associated with increased Ito in ventricular myocytes. This association 
may occur because of a direct influence of KCNE4 on potassium channels responsible for 
Ito or alternatively because of an indirect effect, but our studies are not designed to 
differentiate between these two molecular mechanisms. 
For experiments with Ito blockers, we are severely limited by the lack of highly 
specific agents. It may be useful to test whether wild-type mice treated with a 
pharmacological Ito activator exhibit impaired contractility. We are aware of one such 
compound (NS5806 from NeuroSearch), and could potentially use this agent to test 
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whether Ito augmentation is a plausible mechanism underlying impaired contractility in 
mice.  
We recognize that impaired contractility in Kcne4 knockout mice could have an 
extra-cardiac (neural, humoral, etc) etiology.  To rule out this possibility we could 
engineer a mouse line with cardiac-specific Kcne4 knockout with Cre/lox recombination 
technology and assess whether the contracile phenotype disappears despite normal Kcne4 
expression in extra-cardiac tissues. 
Finally, as addressed above, it is critical to assess any cardiac findings from the 
Kcne4-null mouse in a model that more closely resembles human cardiac 
electrophysiology. If Ito is a target of Kcne4 modulation in mice and its modulation has 
implications for Ca2+ signaling and myocyte contractility, then it is difficult to predict 
what the implications are for human cardiac physiology, for a number of reasons. As 
previously noted, different K+ currents account for repolarization in mouse versus human 
myocytes; additionally, the relationship between repolarization time and contractility is 
dichotomous across rodents and humans. It will thus be critical to study early 
repolarization, Ca2+ signaling, and cell shortening in guinea pig or rabbit myocytes upon 
Kcne4 overexpression or silencing to be able to apply findings in mice toward better 
understanding human physiology. 
 
3. What is the etiology of non-cardiac phenotypes of the Kcne4-knockout mouse? 
For this project we chose to focus on characterizing cardiac phenotypes of the 
Kcne4-null mouse, but recognize that there may be important consequences to Kcne4 
knockout beyond cardiac physiology. The broad expression of KCNE4 (observed most 
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prominently in kidney, skeletal muscle, testis, prostate, spleen, ovary, and uterus) 
suggests that it may contribute to important physiologic processes in a number of tissues. 
Further, other members of the KCNE family have previously been implicated in non-
cardiac physiology – notably, KCNE1 in K+ flux in hair cells of the inner ear that 
contributes to hearing61, KCNE2 in K+ flux that drives thyroid hormone synthesis110 and 
acid secretion by the stomach13, and KCNE3 in skeletal muscle excitability65. 
The data set generated by Lexicon’s multi-system survey of Kcne4-/- mouse 
physiology provides us with several interesting leads, but these data must be interpreted 
in the context of a major limitation: that the studies were performed on F2 mice on a 
hybrid background. Given that significant physiological differences exist among the 
C57BL/6 and 129S6/SvEv strains, variability in genetic background among mice in the 
F2 generation makes it difficult to attribute any differences observed among groups of 
mice specifically to their Kcne4 genotype. Before proceeding with any proposed follow-
up studies, the original findings comparing Kcne4-/- mice to wild-type mice should be 
confirmed in congenic strains. 
The most striking of Lexicon’s findings included: decreased body temperature and 
resting heart rate, and elevated blood phosphate (P042-) and free Ca2+ levels in Kcne4-/- 
versus wild-type mice. Collectively, these findings point toward potential metabolic 
disorders, which could signal impaired thyroid, parathyroid, or kidney function. The 
following experiments are proposed to pursue whether the absence of Kcne4 affects any 
of these physiologic systems. 
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A. Decreased body temperature and bradycardia 
The findings of decreased body temperature and bradycardia are suggestive of 
hypothyroidism. Roepke et al.110 recently demonstrated that K+ flux through a channel 
complex comprised of KCNQ1 and KCNE2 subunits is necessary for I- uptake by 
thyrocytes and normal thyroid hormone synthesis, which leads us to hypothesize that 
KCNE4 may be an endogenous modulator of this current, possibly causing impaired 
thyroid hormone synthesis in Kcne4-/- mice. Further phenotypic characterization of 
Kcne4-/- mice at both the whole-animal and molecular levels will allow us to test this 
hypothesis. 
Assessment of thyroid function in Kcne4-/- mice should include analysis of the gross 
morphology of the thyroid and histology of thyroid follicular epithelia. Further, plasma 
levels of T3, T4, and TSH can be measured by ELISA and compared among Kcne4-/- and 
Kcne4+/+ littermates, along with I- uptake by positron emission tomography (PET) 
imaging to detect specific deficiencies. Depending on the findings of these experiments, 
rescue experiments can be performed (e.g. administration of T4 in Kcne4-/- mice if T4 
levels are low) to further assess whether thyroid deficits are responsible for low body 
temperature and bradycardia in Kcne4-/- mice. 
If impaired thyroid function is confirmed in Kcne4-/- mice, further experiments will 
be needed to uncover the molecular link between Kcne4 and thyroid hormone production. 
The TSH-sensitive K+ current generated by KCNQ1-KCNE2 channel complexes in 
thyrocytes may be a target of KCNE4 modulation and is the most obvious candidate 
linking KCNE4 to thyroid hormone production. To study this possibility it will be 
important to assess whether KCNE4 co-localizes or forms complexes with KCNQ1 and 
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KCNE2 in thyrocytes. Further, we can assess KCNE4 modulation of this current under 
basal and TSH-stimulated conditions using the rat thyroid-derived cell line FRTL5 and 
KCNE4 overexpression and gene silencing approaches described above for guinea pig 
and rabbit cardiac myocytes. 
Anticipated Results: If low body temperature and bradycardia in Kcne4-/- mice are 
attributable to primary hypothyroidism, we would expect these studies to show reduced 
T3 and/or T4 levels, elevated TSH levels, and enlarged thyroid glands and/or abnormal 
gland architecture in Kcne4-/- mice. Further, we would expect to be able to normalize 
body temperature and heart rate upon administration of synthetic thyroid hormone. If 
KCNE4 contributes to thyroid hormone synthesis by modulation of thyrocyte KCNQ1-
KCNE2 channels, we would expect to find co-localization of these subunits in native 
thyrocytes and altered biophysical properties of the current upon KCNE4 overexpression 
or silencing in FLTR5 cells. 
Experimental Limitations: These studies consider primary hypothyroidism as a 
potential etiology for reduced body temperature and bradycardia, but related possibilities 
not addressed include pituitary dysfunction causing secondary hypothyroidism, or 
systemic defects in responsiveness to thyroid hormone. Because the thyrocyte KCNQ1-
KCNE2 channel complex provides an obvious potential link to primary hypothyroidism, 
this etiology should be assessed first. 
 
B. Impaired Ca2+ and PO42- homeostasis 
Parathyroid hormone (PTH) and calcitonin are two important regulators of plasma 
Ca2+ and PO42- levels, and thus they capture our attention when considering findings of 
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elevated Ca2+ and PO42-  in Kcne4-/- mice. The parathyroid releases PTH upon sensing 
low free Ca2+ in the blood, and the effects of PTH include: stimulating osteoclasts to 
release Ca2+ and PO42-  from bone into the blood, stimulating vitamin D production by the 
kidney, which in turn stimulates intestinal epithelial cells to synthesize a Ca2+-binding 
protein to increase Ca2+ absorption from the gut, and stimulating the kidney to reabsorb 
more Ca2+ and excrete more phosphate in the urine. Conversely, calcitonin (produced by 
parafollicular cells in the thyroid) acts to reduce free Ca2+ levels in the blood by 
inhibiting release of Ca2+ and phosphate by osteoclasts and inhibiting tubular 
reabsorption of Ca2+ and phosphate in the kidney. 
Although none of these processes has been directly linked to K+ channel activity, 
we can speculate which points along the pathways might be affected by KCNE4 function, 
potentially contributing to a phenotype of increased Ca2+ and PO42-  in Kcne4-/- mice.  
They include: impaired calcium sensing by the calcium-sensing receptor (CaR), which 
acts upstream of PTH and calcitonin release in the parathyroid and thyroid parafollicular 
cells; hyperactive PTH production; hypersensitive or constitutively active PTH receptors 
in osteoclasts or kidney; augmented vitamin D production by the kidney; impaired 
calcitonin production; or impaired responsiveness to calcitonin in osteoclasts or kidney. 
The molecular mechanisms that regulate many of the processes described above are 
poorly understood, especially with respect to any dependence on K+ flux. Thus we must 
begin with a very broad investigation of the etiology of increased Ca2+ and PO42-  in 
Kcne4-/- mice, for example by comparing basal PTH, calcitonin, and vitamin D levels in 
Kcne4-/- versus Kcne4+/+ mice. Additionally, we can assess gross morphology and 
histological features of the parathyroid and parafollicular cells of the thyroid from Kcne4-
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/- mice for evidence of pathology. Expression of KCNE4 in these tissues plus osteoclasts 
should also be surveyed, as no studies have yet reported on KCNE4 expression by these 
cell types. Finally, bone density and calcification should be examined in Kcne4-/- mice for 
signs of excessive PTH stimulation of osteoclasts. 
Anticipated Findings: The experiments described here should help identify if PTH, 
calcitonin, or Vitamin D are implicated in the findings of elevated Ca2+ and P in Kcne4-/- 
mice. If one function of KCNE4 is to contribute to regulation of any of these factors, we 
might expect to see differences in their levels among Kcne4+/+ and Kcne4-/- mice. If such 
differences are observed, rescue experiments where applicable (i.e., administering a 
hormone found to be deficient in Kcne4-/- mice) might be useful in corroborating the link 
to elevated blood levels of free Ca2+ and PO42-. 
Experimental Limitations: We are limited to a very broad assessment of potential 
pathways that Kcne4 may contribute to in Ca2+ and PO42-  homeostasis, due to limited 
existing data describing molecular mechanisms that underlie these processes in normal 
physiology. Whereas these studies might identify gross abnormalities (such as impaired 
hormone production), more subtle defects will be more difficult to detect. For example, if 
Kcne4 modulates a K+ current that normally attenuates the intestinal epithelial response 
to vitamin D, the Kcne4-null mouse might have an augmented response to vitamin D (ie. 
excessive absorption of Ca2+) without showing abnormal levels of vitamin D or PTH. 
Further, these studies likely will not provide satisfying answers as to how Kcne4 
contributes to Ca2+ and PO42- homeostasis at the molecular level, but the findings they 
generate can be used to guide further investigation. 
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